Richard D. Sontheimer
( out of 309 reviews )

Richard D. Sontheimer, MD

Languages spoken: English

Clinical Locations

Midvalley Health Center

Murray
801-581-2955

University of Utah Hospital

Dermatology, Area E
Salt Lake City
801-581-2955

  • Richard D. Sontheimer, MD, Professor of Dermatology has specialized expertise in the diagnosis and treatment of skin changes that occur in autoimmune rheumatic (arthritic) diseases like lupus, dermatomyositis, scleroderma, and vasculitis. He is Board certified in Internal Medicine, Dermatology and Dermatologic Immunology, and Diagnostic Laboratory Immunology. Dr. Sontheimer's main focus is patient care, education, and patient-oriented translational clinical research.

    Dr. Sontheimer is recognized internationally for his clinical expertise and research accomplishments relating to the skin problems experienced by lupus and dermatomyositis patients. He has been listed in Best Doctors of America and America's Top Doctors and has been elected to several prestigious medical and scientific research societies including the American Society of Clinical Investigation and Association of American Physicians.

    Specialties

    Board Certification

    American Board of Dermatology (Dermatological Immunology/Diagnostic Laboratory Immunology)
    American Board of Dermatology (Dermatology)
    American Board of Internal Medicine (Internal Medicine)

    Patient Rating

    4.9 /5
    ( out of 309 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    October 29, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Dr. Sontheimer is an excellent dermatologist!

    October 16, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Fantastic Doctor, respectful- knowledgeable-explains what needs to be done and why, he makes sure you understand and ask if you have any questions. I was very comfortable with his approach to every aspect of my visit. I would recommend Dr.Sontheimer 1000 percent. It's not often you come across a Doctor with his knowledge and years of experience that still has a great bed side manner,

    October 10, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Genuinely cares and explains things very well!!

    October 10, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Wonderful, professional, and kind.

    October 10, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Have already recommended him to my son

    October 09, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Excellent. Felt heard and not rushed. Wonderful experience!

    October 08, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    The doctor Richard he is very nice. He treat me really well and he care about my health and he referred me to specialist for my scalp. I appreciate your help doctor.

    September 26, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    excellent, professional dermatologist with many years experience

    September 19, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    My experience with the dermatology appointment was outstanding from start to finish. The scheduling process was incredibly efficient'I received a response and booked an appointment within an hour, which was amazing. The appointment itself was right on time, and there were no scheduling conflicts. The medical assistant was professional and attentive, validating my concerns and answering all of my questions. The dermatologist thoroughly addressed all of my concerns, provided a clear treatment plan, and I never felt rushed. I also appreciated receiving a referral for further care.

    See More Patient Comments

  • Richard D. Sontheimer, MD, Professor of Dermatology has specialized expertise in the diagnosis and treatment of skin changes that occur in autoimmune rheumatic (arthritic) diseases like lupus, dermatomyositis, scleroderma, and vasculitis. He is Board certified in Internal Medicine, Dermatology and Dermatologic Immunology, and Diagnostic Laboratory Immunology. Dr. Sontheimer's main focus is patient care, education, and patient-oriented translational clinical research.

    Dr. Sontheimer is recognized internationally for his clinical expertise and research accomplishments relating to the skin problems experienced by lupus and dermatomyositis patients. He has been listed in Best Doctors of America and America's Top Doctors and has been elected to several prestigious medical and scientific research societies including the American Society of Clinical Investigation and Association of American Physicians.

    Board Certification and Academic Information

    Academic Departments Dermatology -Primary
    Board Certification
    American Board of Dermatology (Dermatological Immunology/Diagnostic Laboratory Immunology)
    American Board of Dermatology (Dermatology)
    American Board of Internal Medicine (Internal Medicine)

    Education history

    Residency Dermatology - University of Texas Southwestern Medical School Resident
    University of Texas Southwestern Medical School Research Fellow
    Residency Internal Medicine - University of Utah School of Medicine Resident
    Medicine - University of Utah School of Medicine Intern
    Professional Medical Medicine - University of Texas Southwestern M.D.
    Tulane University B.S.

    Selected Publications

    Journal Article

    1. Blue E, Abbott J, Laggis C, Duffy K, Sontheimer RD, Klein S (). Clinical pathological challenge: Non-healing right lower leg ulcer. (Epub ahead of print) Am J Dermatopathol.
    2. Concha JSS, Pena S Gaffney RG, Sontheimer RD, etal (). Developing Classification criteria for skin-predominant dermatomyositis: the Delphi process. [Epub ahead of print]. (Epub ahead of print) Br J Dermatol.
    3. Logan S, Sontheimer RD (). Concurrence of erythema elevatum diutinum and HIV infection: A case report and literature review. (Epub ahead of print) J Am Acad Dermatol.
    4. Sontheimer RD, Werth VP, Connolly MK (). Meeting Report-10th Annual Meeting of the Rheumatologic Dermatology Society. (Epub ahead of print) Ann Transl Med.
    5. Bormann JL, Petersen MJ, Sontheimer RD, Zussman J (2024). A confounding clinically aggressive case of necrotizing granulomatous and suppurative dermatitis. Dermatol Online J, 30(1). (Read full article)
    6. Bormann JL, Petersen MJ, Sontheimer RD, Zussman J (2024). A confounding clinically aggressive case of necrotizing granulomatous and suppurative dermatitis. Dermatol Online J, 30(1). (Read full article)
    7. Dao DP, Sahni DR, Sontheimer RD (2023). Linear discoid lupus erythematous simulating en coup de sabre morphea in a female chronic granulomatous disease carrier. Dermatol Online J, 29(6). (Read full article)
    8. Marcelus C, Jimenez A, Zussman J, Hansen CB, Sontheimer RD (2022). Questions raised by a case of adult-onset linear nodular scleroderma. Dermatol Online J, 28(5). (Read full article)
    9. Westerdahl JS, Grant J, Sontheimer R, Zussman J (2021). Darier disease, radiation therapy, and herpesvirus -- an unfortunate triad. Dermatol Online J, 27(8). (Read full article)
    10. Blue E, Abbott J, Laggis C, Duffy K, Sontheimer R, Klein S (2019). Nonhealing Right Lower Leg Ulcer: Challenge. Am J Dermatopathol, 43(1), e3-e4. (Read full article)
    11. Blue E, Abbott J, Laggis C, Duffy K, Sontheimer R, Klein S (2020). Nonhealing Right Lower Leg Ulcer: Answer. Am J Dermatopathol, 43(1), 77. (Read full article)
    12. Yan D, Borucki R, Sontheimer RD, Werth VP (2020). Candidate drug replacements for quinacrine in cutaneous lupus erythematosus. Lupus Sci Med, 7(1). (Read full article)
    13. Freeman C, Hull C, Sontheimer R, Curtis J (2020). Squamous cell carcinoma of the dorsal hands and feet after repeated exposure to ultraviolet nail lamps. Dermatol Online J, 26(3). (Read full article)
    14. Concha JSS, Pena S, Gaffney RG, Patel B, Tarazi M, Kushner CJ, Merola JF, Fiorentino D, Dutz JP, Goodfield M, Nyberg F, Volc-Platzer B, Fujimoto M, Ang CC, Werth VP, Skin Myositis Delphi Group (2019). Developing classification criteria for skin-predominant dermatomyositis: the Delphi process. Br J Dermatol, 182(2), 410-417. (Read full article)
    15. Sontheimer RD, Werth VP, Connolly MK (2019). 10th Annual Meeting of the Rheumatologic Dermatology Society. Ann Transl Med, 7(Suppl 4), S159. (Read full article)
    16. Li B, Sontheimer RD (2018). Meet the Professor - Richard D. Sontheimer: “Inveterate curiosity” is the fundamental character trait of a “doctors’ doctor.”  http://atm.amegroups.com/article/view/21858/pdf. Ann Transl Med.
    17. Sontheimer RD (2018). James Neil Gilliam, MD-the career arc of a patient-oriented translational clinical investigation changemaker in rheumatologic skin disease. Ann Transl Med, 6(11), 217. (Read full article)
    18. Sontheimer RD (2018). Aminoquinoline antimalarial therapy in dermatomyositis-are we missing opportunities with respect to comorbidities and modulation of extracutaneous disease activity? Ann Transl Med, 6(8), 154. (Read full article)
    19. Brummer GC, Wang LT, Sontheimer RD (2018). A possible role for dupilumab (Dupixent) in the management of idiopathic chronic eczematous eruption of aging. Dermatol Online J, 24(2). (Read full article)
    20. Summers EM, Blickenstaff NR, Coman GC, Martins TB, Hill HR, Sontheimer RD (2017). A pilot study evaluating biomarker development for drug-induced chronic eczematous eruptions of aging individuals. Ann Transl Med, 5(20), 393. (Read full article)
    21. Sontheimer RD (2017). MDA5 autoantibody-another indicator of clinical diversity in dermatomyositis. Ann Transl Med, 5(7), 160. (Read full article)
    22. Michaelis TC, Sontheimer RD, Lowe GC (2017). An update in drug-induced subacute cutaneous lupus erythematosus. Dermatol Online J, 23(3). (Read full article)
    23. McBride JD, Sontheimer RD (2016). Proximal nailfold microhemorrhage events are manifested as distal cuticular (eponychial) hemosiderin-containing deposits (CEHD) (syn. Maricq sign) and can aid in the diagnosis of dermatomyositis and systemic sclerosis.LID - 13030/qt8sr306pb [pii]. Dermatol Online J, 22(2). (Read full article)
    24. Eliason MJ, Sontheimer RD (2015). How to reduce out-of-pocket costs for prescription medications.LID - 13030/qt5bk5n1vj [pii]. Dermatol Online J, 21(6). (Read full article)
    25. Summers EM, Bingham CS, Dahle KW, Sweeney C, Ying J, Sontheimer RD (2013). Chronic eczematous eruptions in the aging: further support for an association with exposure to calcium channel blockers. JAMA Dermatol, 149(7), 814-8. (Read full article)
    26. Ghazi E, Sontheimer RD, Werth VP (2013). The importance of including amyopathic dermatomyositis in the idiopathic inflammatory myositis spectrum. Clin Exp Rheumatol, 31(1), 128-34. (Read full article)
    27. Dahle KW, Sontheimer RD (2012). The Rudolph sign of nasal vestibular furunculosis: questions raised by this common but under-recognized nasal mucocutaneous disorder. Dermatol Online J, 18(3), 6. (Read full article)
    28. Li Y, Foshee JB, Sontheimer RD (2010). Sustained clinical response to rituximab in a case of life-threatening overlap subepidermal autoimmune blistering disease. J Am Acad Dermatol, 64(4), 773-8. (Read full article)
    29. Lowe GC, Henderson CL, Grau RH, Hansen CB, Sontheimer RD (2011). A systematic review of drug-induced subacute cutaneous lupus erythematosus. Br J Dermatol, 164(3), 465-72. (Read full article)
    30. Sontheimer, RD (09/01/2010). Unbent, Unbroken. Hektoen International. J Med Humanit, 2(3).
    31. Sontheimer RD (2010). North american rheumatologic dermatology society meeting report. Arch Dermatol, 146(9), 999. (Read full article)
    32. Obermoser G, Sontheimer RD, Zelger B (2010). Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates. Lupus, 19(9), 1050-70. (Read full article)
    33. Davila M, Christenson LJ, Sontheimer RD (2010). Epidemiology and outcomes of dermatology in-patient consultations in a Midwestern U.S. university hospital. Dermatol Online J, 16(2), 12. (Read full article)
    34. Walling HW, Gerami P, Sontheimer RD (2010). Juvenile-onset clinically amyopathic dermatomyositis: an overview of recent progress in diagnosis and management. Paediatr Drugs, 12(1), 23-34. (Read full article)
    35. Nuzum-Keim AD, Sontheimer RD (2009). Ultraviolet light output of compact fluorescent lamps: comparison to conventional incandescent and halogen residential lighting sources. Lupus, 18(6), 556-60. (Read full article)
    36. Nuzum-Keim, A, Sontheimer RD (2009). Ultraviolet light output of compact fluorescent lamps: comparison to conventional incandescent and halogen residential lighting sources. Lupus, 18(6), 556-560.
    37. Dugan EM, Huber AM, Miller FW, Rider LG, International Myositis Assessment and Clinical Studies Group (2009). Photoessay of the cutaneous manifestations of the idiopathic inflammatory myopathies. Dermatol Online J, 15(2), 1.
    38. Walling HW, Sontheimer RD (2009). Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am J Clin Dermatol, 10(6), 365-81. (Read full article)
    39. Sontheimer RD, Henderson CL, Grau RH (2009). Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation. Arch Dermatol Res, 301(1), 65-70. (Read full article)
    40. Klein RQ, Bangert CA, Costner M, Connolly MK, Tanikawa A, Okawa J, Rose M, Fakharzadeh SS, Fiorentino D, Lee LA, Sontheimer RD, Taylor L, Troxel AB, Werth VP (2008). Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis. Br J Dermatol, 159(4), 887-94. (Read full article)
    41. Lin JH, Dutz JP, Sontheimer RD, Werth VP (2007). Pathophysiology of cutaneous lupus erythematosus. Clin Rev Allergy Immunol, 33(1-2), 85-106. (Read full article)
    42. Gerami P, Walling HW, Lewis J, Doughty L, Sontheimer RD (2007). A systematic review of juvenile-onset clinically amyopathic dermatomyositis. Br J Dermatol, 157(4), 637-44. (Read full article)
    43. Gerami P, Schope JM, McDonald L, Walling HW, Sontheimer RD (2006). A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol, 54(4), 597-613. (Read full article)
    44. Sontheimer RD, Racila E, Racila DM (2005). C1q: its functions within the innate and adaptive immune responses and its role in lupus autoimmunity. J Invest Dermatol, 125(1), 14-23. (Read full article)
    45. Sontheimer RD (2004). The management of dermatomyositis: current treatment options. Expert Opin Pharmacother, 5(5), 1083-99. (Read full article)
    46. Sontheimer RD (2004). A portable digital microphotography unit for rapid documentation of periungual nailfold capillary changes in autoimmune connective tissue diseases. J Rheumatol, 31(3), 539-44. (Read full article)
    47. Wu Q, Fu YX, Sontheimer RD (2004). Blockade of lymphotoxin signaling inhibits the clinical expression of murine graft-versus-host skin disease. J Immunol, 172(3), 1630-6. (Read full article)
    48. Albrecht J, Berlin JA, Braverman IM, Callen JP, Connolly MK, Costner MI, Dutz J, Fivenson D, Franks AG, Jorizzo JL, Lee LA, McCauliffe DP, Sontheimer RD, Werth VP (2004). Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus. Lupus, 13(11), 839-49. (Read full article)
    49. Ting WW, Vest CD, Sontheimer R (2003). Practical and experimental consideration of sun protection in dermatology. Int J Dermatol, 42(7), 505-13. (Read full article)
    50. Lotery HE, Galask RP, Stone MS, Sontheimer RD (2003). Ulcerative vulvitis in atypical Reiter's syndrome. J Am Acad Dermatol, 48(4), 613-6. (Read full article)
    51. Racila DM, Sontheimer CJ, Sheffield A, Wisnieski JJ, Racila E, Sontheimer RD (2003). Homozygous single nucleotide polymorphism of the complement C1QA gene is associated with decreased levels of C1q in patients with subacute cutaneous lupus erythematosus. Lupus, 12(2), 124-32. (Read full article)
    52. Sontheimer RD (2002). Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin, 20(3), 387-408. (Read full article)
    53. Sontheimer RD (2002). Skin disease in dermatomyositis--what patients and their families often want to know. Dermatol Online J, 8(1), 6. (Read full article)
    54. Sontheimer RD (2002). Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis siné myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol, 46(4), 626-36. (Read full article)
    55. Werth VP, Voorhees J, Freedberg IM, Sontheimer RD (2001). Preserving medical dermatology. A colleague lost, a call to arms, and a plan for battle. Dermatol Clin, 19(4), 583-92. (Read full article)
    56. Orteu CH, Sontheimer RD, Dutz JP (2001). The pathophysiology of photosensitivity in lupus erythematosus. Photodermatol Photoimmunol Photomed, 17(3), 95-113. (Read full article)
    57. Scofield RH, Racila DM, Gordon TP, Kurien BT, Sontheimer RD (2000). Anti-calreticulin segregates anti-Ro sera in systemic lupus erythematosus: anti-calreticulin is present in sera with anti-Ro alone but not in anti-Ro sera with anti-La or anti-ribonucleoprotein. J Rheumatol, 27(1), 128-34. (Read full article)
    58. Yang Y, Eversole T, Lee DJ, Sontheimer RD, Capra JD (1999). Protein-protein interactions between native Ro52 and immunoglobulin G heavy chain. Scand J Immunol, 49(6), 620-8. (Read full article)
    59. Racila DM, Sontheimer RD (1999). C1q inhibits autoantibody binding to calreticulin. Lupus, 8(4), 300-4. (Read full article)
    60. Sontheimer RD, Werth VP (1998). Whither the patient-oriented researcher? . J Am Acad Dermatol, 39(1), 109-13. (Read full article)
    61. Nguyen TQ, Capra JD, Sontheimer RD (1998). 4-Aminoquinoline antimalarials enhance UV-B induced c-jun transcriptional activation. Lupus, 7(3), 148-53. (Read full article)
    62. Kinoshita G, Keech CL, Sontheimer RD, Purcell A, McCluskey J, Gordon TP (1998). Spreading of the immune response from 52 kDaRo and 60 kDaRo to calreticulin in experimental autoimmunity. Lupus, 7(1), 7-11. (Read full article)
    63. Werth VP, Dutz JP, Sontheimer RD (1997). Pathogenetic mechanisms and treatment of cutaneous lupus erythematosus. Curr Opin Rheumatol, 9(5), 400-9. (Read full article)
    64. Kishore U, Sontheimer RD, Sastry KN, Zappi EG, Hughes GR, Khamashta MA, Reid KB, Eggleton P (1997). The systemic lupus erythematosus (SLE) disease autoantigen-calreticulin can inhibit C1q association with immune complexes. Clin Exp Immunol, 108(2), 181-90. (Read full article)
    65. Denfeld RW, Kind P, Sontheimer RD, Schpf E, Simon JC (1997). In situ expression of B7 and CD28 receptor families in skin lesions of patients with lupus erythematosus. Arthritis Rheum, 40(5), 814-21. (Read full article)
    66. Kishore U, Sontheimer RD, Sastry KN, Zaner KS, Zappi EG, Hughes GR, Khamashta MA, Strong P, Reid KB, Eggleton P (1997). Release of calreticulin from neutrophils may alter C1q-mediated immune functions. Biochem J, 322 ( Pt 2), 543-50. (Read full article)
    67. Lieu TS, Sontheimer RD (1997). A subpopulation of WIL-2 cell calreticulin molecules is associated with RO/SS-A ribonucleoprotein particles. Lupus, 6(1), 40-7. (Read full article)
    68. Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Skouge JW, Webster SB, Whitaker DC, Butler B, Lowery BJ, Sontheimer RD, Callen JP, Camisa C, Provost TT, Tuffanelli DL (1996). Guidelines of care for scleroderma and sclerodermoid disorders. American Academy of Dermatology. J Am Acad Dermatol, 35(4), 609-14. (Read full article)
    69. Pogue GP, Hofmann J, Duncan R, Best JM, Etherington J, Sontheimer RD, Nakhasi HL (1996). Autoantigens interact with cis-acting elements of rubella virus RNA. J Virol, 70(9), 6269-77. (Read full article)
    70. Cheng ST, Nguyen TQ, Yang YS, Capra JD, Sontheimer RD (1996). Calreticulin binds hYRNA and the 52-kDa polypeptide component of the Ro/SS-A ribonucleoprotein autoantigen. J Immunol, 156(11), 4484-91. (Read full article)
    71. Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Skouge JW, Webster SB, Whitaker DC, Butler B, Lowery BJ, Sontheimer RD, Callen JP, Camisa C, Provost TT, Tuffanelli DL (1996). Guidelines of care for cutaneous lupus erythematosus. American Academy of Dermatology. J Am Acad Dermatol, 34(5 Pt 1), 830-6. (Read full article)
    72. Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Skouge JW, Webster SB, Whitaker DC, Butler B, Lowery BJ, Sontheimer RD, Callen JP, Camisa C, Provost TT, Tuffanelli DL (1996). Guidelines of care for dermatomyositis. American Academy of Dermatology. J Am Acad Dermatol, 34(5 Pt 1), 824-9. (Read full article)
    73. Sontheimer RD (1996). Photoimmunology of lupus erythematosus and dermatomyositis: a speculative review. Photochem Photobiol, 63(5), 583-94. (Read full article)
    74. Nguyen TO, Capra JD, Sontheimer RD (1996). Calreticulin is transcriptionally upregulated by heat shock, calcium and heavy metals. Mol Immunol, 33(4-5), 379-86. (Read full article)
    75. Bijwaard K, Hearing VJ, Sontheimer R, Lieu TS, Vieira WD, Gersten DM (1995). Studies on the expression and immunogenicity of the B50 melanoma antigen and its relationship with calreticulin. Melanoma Res, 5(5), 327-36. (Read full article)
    76. Zieglschmid-Adams ME, Pandya AG, Cohen SB, Sontheimer RD (1995). Treatment of dermatomyositis with methotrexate. J Am Acad Dermatol, 32(5 Pt 1), 754-7. (Read full article)
    77. Pandya AG, Sontheimer RD, Cockerell CJ, Takashima A, Piepkorn M (1995). Papulonodular mucinosis associated with systemic lupus erythematosus: possible mechanisms of increased glycosaminoglycan accumulation. J Am Acad Dermatol, 32(2 Pt 1), 199-205. (Read full article)
    78. Wisnieski JJ, Baer AN, Christensen J, Cupps TR, Flagg DN, Jones JV, Katzenstein PL, McFadden ER, McMillen JJ, Pick MA, Richmond GW, Simon SR, Smith HR, Sontheimer RD, Trigg LB, Weldon D, Zone JJ (1995). Hypocomplementemic urticarial vasculitis syndrome. Medicine (Madr), 74(1), 24-41.
    79. Kawashima T, Zappi EG, Lieu TS, Sontheimer RD (1994). Impact of ultraviolet irradiation on expression of SSA/Ro autoantigenic polypeptides in transformed human epidermal keratinocytes. Lupus, 3(6), 493-500. (Read full article)
    80. Euwer RL, Sontheimer RD (1994). Dermatologic aspects of myositis. Curr Opin Rheumatol, 6(6), 583-9. (Read full article)
    81. Houpt KR, Sontheimer RD (1994). Autoimmune connective tissue disease and connective tissue disease-like illnesses after silicone gel augmentation mammoplasty. J Am Acad Dermatol, 31(4), 626-42. (Read full article)
    82. Eggleton P, Lieu TS, Zappi EG, Sastry K, Coburn J, Zaner KS, Sontheimer RD, Capra JD, Ghebrehiwet B, Tauber AI (1994). Calreticulin is released from activated neutrophils and binds to C1q and mannan-binding protein. Clin Immunol Immunopathol, 72(3), 405-9. (Read full article)
    83. Kawashima T, Zappi EG, Lieu TS, Sontheimer RD (1994). Impact of ultraviolet radiation on the cellular expression of Ro/SS-A-autoantigenic polypeptides. Dermatology, 189 Suppl 1, 6-10. (Read full article)
    84. Sontheimer RD (1993). A young woman with a photosensitive butterfly facial rash, fatigue, anemia, and positive antinuclear antibody. Arthritis Rheum, 36(6), 871-4. (Read full article)
    85. Zappi E, Sontheimer R (1993). Clinical relevance of antibodies to Ro/SS-A and La/SS-B in subacute cutaneous lupus erythematosus and related conditions. Immunol Invest, 22(3), 189-203. (Read full article)
    86. McCauliffe DP, Sontheimer RD (1993). Molecular characterization of the Ro/SS-A autoantigens. J Invest Dermatol, 100(1), 73S-79S. (Read full article)
    87. Euwer RL, Sontheimer RD (1993). Amyopathic dermatomyositis: a review. J Invest Dermatol, 100(1), 124S-127S. (Read full article)
    88. Simon JC, Thiele DL, Schpf E, Sontheimer RD (1992). Effects of the immunosuppressive dipeptide L-leucyl-L-leucine O-methyl ester on epidermal Langerhans cells. J Invest Dermatol, 99(5), 80S-82S. (Read full article)
    89. Zappi E, Sontheimer R (1992). Clinical relevance of antibodies to Ro/SS-A and La/SS-B in subacute cutaneous lupus erythematosus and related conditions. Clin Dermatol, 10(4), 431-41. (Read full article)
    90. Black AA, McCauliffe DP, Sontheimer RD (1992). Prevalence of acne rosacea in a rheumatic skin disease subspecialty clinic. Lupus, 1(4), 229-37. (Read full article)
    91. Lux FA, McCauliffe DP, Bttner DW, Lucius R, Capra JD, Sontheimer RD, Lieu TS (1992). Serological cross-reactivity between a human Ro/SS-A autoantigen (calreticulin) and the lambda Ral-1 antigen of Onchocerca volvulus. J Clin Invest, 89(6), 1945-51. (Read full article)
    92. McCauliffe DP, Yang YS, Wilson J, Sontheimer RD, Capra JD (1992). The 5'-flanking region of the human calreticulin gene shares homology with the human GRP78, GRP94, and protein disulfide isomerase promoters. J Biol Chem, 267(4), 2557-62. (Read full article)
    93. Asherson RA, Sontheimer R (1991). Urticarial vasculitis and syndromes in association with connective tissue diseases. Ann Rheum Dis, 50(11), 743-4. (Read full article)
    94. Sontheimer RD, Lieu TS, McCauliffe DP (1991). Molecular characterization of the Ro/SS-A autoimmune response. Semin Dermatol, 10(3), 199-205. (Read full article)
    95. Brown C, Lieu TS, Sontheimer RD (1991). Correlation between dermal interstitial immunoglobulin G and hypergammaglobulinemia. J Invest Dermatol, 97(2), 373-7. (Read full article)
    96. Euwer RL, Sontheimer RD (1991). Amyopathic dermatomyositis (dermatomyositis siné myositis). Presentation of six new cases and review of the literature. J Am Acad Dermatol, 24(6 Pt 1), 959-66. (Read full article)
    97. Simon JC, Cruz PD Jr, Tigelaar RE, Sontheimer RD, Bergstresser PR (1991). Adhesion molecules CD11a, CD18, and ICAM-1 on human epidermal Langerhans cells serve a functional role in the activation of alloreactive T cells. J Invest Dermatol, 96(1), 148-51. (Read full article)
    98. Rao BK, Coldiron B, Freeman RG, Sontheimer RD (1990). Subacute cutaneous lupus erythematosus lesions progressing to morphea. J Am Acad Dermatol, 23(5 Pt 2), 1019-22. (Read full article)
    99. Milewich L, Sontheimer RD, Herndon JH Jr (1990). Steroid sulfatase activity in epidermis of acne-prone and non-acne-prone skin of patients with acne vulgaris. Arch Dermatol, 126(10), 1312-4. (Read full article)
    100. McCauliffe DP, Zappi E, Lieu TS, Michalak M, Sontheimer RD, Capra JD (1990). A human Ro/SS-A autoantigen is the homologue of calreticulin and is highly homologous with onchocercal RAL-1 antigen and an aplysia "memory molecule". J Clin Invest, 86(1), 332-5. (Read full article)
    101. Boh E, Roberts LJ, Lieu TS, Gammon WR, Sontheimer RD (1990). Epidermolysis bullosa acquisita preceding the development of systemic lupus erythematosus. J Am Acad Dermatol, 22(4), 587-93. (Read full article)
    102. McCauliffe DP, Lux FA, Lieu T-S, Sanz I, Hanke J, Newkirk MM, Bachinski LL, Itoh Y, Siciliano MJ, Reichlin M, Sontheimer RD, Capra JD (1990). Molecular cloning, expression and chromosome 19 localization of a human Ro/SS-A autoantigen. J Clin Invest, 85, 1379-1391.
    103. Rendon MI, Cruz PD Jr, Sontheimer RD, Bergstresser PR (1989). Acanthosis nigricans: a cutaneous marker of tissue resistance to insulin. J Am Acad Dermatol, 21(3 Pt 1), 461-9. (Read full article)
    104. Sontheimer RD (1989). Subacute cutaneous lupus erythematosus: a decade's perspective. Med Clin North Am, 73(5), 1073-90. (Read full article)
    105. Sontheimer RD (1989). Perivascular dendritic macrophages as immunobiological constituents of the human dermal microvascular unit. J Invest Dermatol, 93(2 Suppl), 96S-101S. (Read full article)
    106. McCauliffe DP, Lux FA, Lieu TS, Sanz I, Hanke J, Newkirk MM, Siciliano MJ, Sontheimer RD, Capra JD (1989). Ro/SS-A and the pathogenic significance of its antibodies. J Autoimmun, 2(4), 375-81. (Read full article)
    107. Lieu TS, Newkirk MM, Arnett FC, Lee LA, Deng JS, Capra JD, Sontheimer RD (1989). A major autoepitope is present on the amino terminus of a human SS-A/Ro polypeptide. J Autoimmun, 2(4), 367-74. (Read full article)
    108. Sontheimer RD, Matsubara T, Seelig LL Jr (1989). A macrophage phenotype for a constitutive, class II antigen-expressing, human dermal perivascular dendritic cell. J Invest Dermatol, 93(1), 154-9. (Read full article)
    109. Davis TL, Lyde CB, Davis BM, Sontheimer RD (1989). Perturbation of experimental ultraviolet light-induced erythema by passive transfer of serum from subacute cutaneous lupus erythematosus patients. J Invest Dermatol, 92(4), 573-7. (Read full article)
    110. McCarley ME, Cruz PD Jr, Sontheimer RD (1988). Chancroid: clinical variants and other findings from an epidemic in Dallas County, 1986-1987. J Am Acad Dermatol, 19(2 Pt 1), 330-7. (Read full article)
    111. Lieu TS, Newkirk MM, Capra JD, Sontheimer RD (1988). Molecular characterization of human Ro/SS-A antigen. Amino terminal sequence of the protein moiety of human Ro/SS-A antigen and immunological activity of a corresponding synthetic peptide. J Clin Invest, 82(1), 96-101. (Read full article)
    112. Coldiron BM, Cruz PD Jr, Freeman RG, Sontheimer RD (1988). Benign non-X histiocytosis: a unique case bridging several of the non-X histiocytic syndromes. J Am Acad Dermatol, 18(6), 1282-9. (Read full article)
    113. Sontheimer RD, Ziff M (1988). Questions pertaining to the etiology and pathophysiology of polymyositis/dermatomyositis. Clin Dermatol, 6(2), 105-19. (Read full article)
    114. Sontheimer RD (1988). Festschrift to Professor James N. Gilliam. Clin Dermatol, 6(2), 1-2. (Read full article)
    115. Lieu TS, Reimer CB, Sontheimer RD (1988). Immunoglobulin class and subclass profile of the Ro/SS-A autoantibody response. J Invest Dermatol, 90(2), 158-64. (Read full article)
    116. Milewich L, Shaw CB, Sontheimer RD (1988). Steroid metabolism by epidermal keratinocytes. Ann N Y Acad Sci, 548, 66-89. (Read full article)
    117. Purcell SM, Lieu TS, Davis BM, Sontheimer RD (1987). Relationship between circulating anti-Ro/SS-A antibody levels and skin disease activity in subacute cutaneous lupus erythematosus. Br J Dermatol, 117(3), 277-87. (Read full article)
    118. Sontheimer RD (1987). The anticardiolipin syndrome. A new way to slice an old pie, or a new pie to slice? Arch Dermatol, 123(5), 590-5. (Read full article)
    119. Roberts LJ, Sontheimer RD (1987). Chronic bullous dermatosis of childhood: immunopathologic studies. Pediatr Dermatol, 4(1), 6-10. (Read full article)
    120. Haskard DO, Cavender D, Fleck RM, Sontheimer R, Ziff M (1987). Human dermal microvascular endothelial cells behave like umbilical vein endothelial cells in T-cell adhesion studies. J Invest Dermatol, 88(3), 340-4. (Read full article)
    121. Cruz PD Jr, Coldiron BM, Sontheimer RD (1987). Concurrent features of cutaneous lupus erythematosus and pemphigus erythematosus following myasthenia gravis and thymoma. J Am Acad Dermatol, 16(2 Pt 2), 472-80. (Read full article)
    122. Sontheimer RD (1987). Questions pertaining to the true frequencies with which anti-Ro/SS-A autoantibody and the HLA-DR3 phenotype occur in subacute cutaneous lupus erythematosus patients. J Am Acad Dermatol, 16(1 Pt 1), 130-4. (Read full article)
    123. Henderson T, Medsger TA Jr, Sontheimer RD, Harmon CE, Deng JS (1987). Specificity of the hydrochloric-acid-modified Crithidia luciliae immunofluorescence assay for detection of antibody to native DNA. Diagn Clin Immunol, 5(1), 20-4. (Read full article)
    124. Roberts LJ, Sontheimer RD (1987). Immunopathology of chronic bullous dermatosis of childhood. Pediatr Dermatol, 4, 6-10.
    125. Deng JS, Bair LW Jr, Medsger TA Jr, Sontheimer RA (1987). Correlation between ANA determinations on tissue substrate, WiL-2 cell substrate, and precipitin antibody by double diffusion. Diagn Clin Immunol, 5(3), 151-7. (Read full article)
    126. Sontheimer RD, Stastny P, Nnez G (1986). HLA-D region antigen expression by human epidermal Langerhans cells. J Invest Dermatol, 87(6), 707-10. (Read full article)
    127. Cohen S, Stastny P, Sontheimer RD (1986). Concurrence of subacute cutaneous lupus erythematosus and rheumatoid arthritis. Arthritis Rheum, 29(3), 421-5. (Read full article)
    128. Kind P, Lipsky PE, Sontheimer RD (1986). Circulating T- and B-cell abnormalities in cutaneous lupus erythematosus. J Invest Dermatol, 86(3), 235-9. (Read full article)
    129. Milewich L, Kaimal V and Sontheimer RD (1986). Epidermal keratinocytes: A source of 5-dihydrotestosterone production in human skin. J Clin Endocrinol Metab, 62, 739-746.
    130. Deng JS, Sontheimer RD, Gilliam JN (1985). Expression of Ro/SS-A antigen in human skin and heart. J Invest Dermatol, 85(5), 412-6. (Read full article)
    131. Sontheimer RD (1985). Subacute cutaneous lupus erythematosus. Clin Dermatol, 3(3), 58-68. (Read full article)
    132. Sontheimer RD (1985). The mixed epidermal cell-lymphocyte reaction. II. Epidermal Langerhans cells are responsible for the enhanced allogeneic lymphocyte-stimulating capacity of normal human epidermal cell suspensions. J Invest Dermatol, 85(1 Suppl), 21s-26s. (Read full article)
    133. Sontheimer RD (1985). Clinical significance of subacute cutaneous lupus erythematosus skin lesions. J Dermatol, 12(3), 205-12. (Read full article)
    134. Deng JS, Sontheimer RD, Lipscomb MF, Gilliam JN (1985). The binding of antihistone antibodies to Crithidia luciliae kinetoplasts is growth cycle-dependent. Arthritis Rheum, 28(2), 163-8. (Read full article)
    135. Deng JS, Sontheimer RD, Gilliam JN (1985). Molecular characteristics of SS-B/La and SS-A/Ro cellular antigens. J Invest Dermatol, 84(2), 86-90. (Read full article)
    136. Deng JS, Rubin RL, Lipscomb MF, Sontheimer RD, Gilliam JN (1984). Reappraisal of the specificity of the Crithidia luciliae assay for nDNA antibodies: evidence for histone antibody kinetoplast binding. Am J Clin Pathol, 82(4), 448-52. (Read full article)
    137. Deng JS, Sontheimer RD, Gilliam JN (1984). Relationships between antinuclear and anti-Ro/SS-A antibodies in subacute cutaneous lupus erythematosus. J Am Acad Dermatol, 11(3), 494-9. (Read full article)
    138. Steinmetz SE, Deng JS, Rubin RL, Sontheimer RD, Gilliam JN (1984). Reevaluation of specificity of Crithidia luciliae kinetoplast as a substrate for detecting antibodies to double-stranded deoxyribonucleic acid. J Am Acad Dermatol, 11(3), 490-3. (Read full article)
    139. Bangert JL, Freeman RG, Sontheimer RD, Gilliam JN (1984). Subacute cutaneous lupus erythematosus and discoid lupus erythematosus. Comparative histopathologic findings. Arch Dermatol, 120(3), 332-7. (Read full article)
    140. Sontheimer RD, Bergstresser PR, Gailiunas P Jr, Helderman JH, Gilliam JN (1984). Perturbation of epidermal Langerhans cells in immunosuppressed human renal allograft recipients. Transplantation, 37(2), 168-74. (Read full article)
    141. Charley MR, Mikhael A, Sontheimer RD, Gilliam JN, Bennett M (1984). Cutaneous mast cell maturation does not depend on an intact bone marrow microenvironment. J Invest Dermatol, 82(1), 25-7. (Read full article)
    142. Charley MR, Bangert JL, Hamilton BL, Gilliam JN, Sontheimer RD (1983). Murine graft-versus-host skin disease: a chronologic and quantitative analysis of two histologic patterns. J Invest Dermatol, 81(5), 412-7. (Read full article)
    143. Charley MR, Mikhael A, Bennett M, Gilliam JN, Sontheimer RD (1983). Prevention of lethal, minor-determinate graft-host disease in mice by the in vivo administration of anti-asialo GM1. J Immunol, 131(5), 2101-3. (Read full article)
    144. Sontheimer RD, Deng JS, Gilliam JN (1983). Antinuclear and anticytoplasmic antibodies. Concepts and misconceptions. J Am Acad Dermatol, 9(3), 335-43. (Read full article)
    145. Sontheimer RD (1983). The mixed epidermal cell-lymphocyte reaction. I. Human epidermal cells elicit a greater allogeneic lymphocyte response than do autologous peripheral blood lymphoid cells. J Immunol, 130(6), 2612-4. (Read full article)
    146. Sontheimer RD, Maddison PJ, Reichlin M, Jordon RE, Stastny P, Gilliam JN (1982). Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med, 97(5), 664-71. (Read full article)
    147. Sontheimer RD, Bergstresser PR (1982). Epidermal Langerhans cell involvement in cutaneous lupus erythematosus. J Invest Dermatol, 79(4), 237-43. (Read full article)
    148. Charley MR, Sontheimer RD (1982). Clearing of subacute cutaneous lupus erythematosus around molluscum contagiosum lesions. J Am Acad Dermatol, 6(4 Pt 1), 529-33. (Read full article)
    149. Sontheimer RD, Gilliam JN (1981). Immunologically mediated epidermal cell injury. Springer Semin Immunopathol, 4(1), 1-15. (Read full article)
    150. Gilliam JN, Sontheimer RD (1981). Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol, 4(4), 471-5. (Read full article)
    151. Sontheimer RD, Stastny P, Gilliam JN (1981). Human histocompatibility antigen associations in subacute cutaneous lupus erythematosus. J Clin Invest, 67(1), 312-6. (Read full article)
    152. Sontheimer RD, Thomas JR, Gilliam JN (1979). Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol, 115(12), 1409-15. (Read full article)
    153. Sontheimer RD, Gilliam JN (1979). A reappraisal of the relationship between subepidermal immunoglobulin deposits and DNA antibodies in systemic lupus erythematosus: a study using the Crithidia luciliae immunofluorescence anti-DNA assay. J Invest Dermatol, 72(1), 29-32. (Read full article)
    154. Sontheimer RD, Gilliam JN (1979). Regional variation in the deposition of subepidermal immunoglobulin in NZB/W F1 mice: association with epidermal DNA synthesis. J Invest Dermatol, 72(1), 25-8. (Read full article)
    155. Chubick A, Sontheimer RD, Gilliam JN, Ziff M (1978). An appraisal of tests for native DNA antibodies in connective tissue diseases. Clinical usefulness of Crithidia luciliae assay. Ann Intern Med, 89(2), 186-92. (Read full article)
    156. Sontheimer RD, Gilliam JN (1978). DNA antibody class, subclass, and complement fixation in systemic lupus erythematosus with and without nephritis. Clin Immunol Immunopathol, 10(4), 459-67. (Read full article)
    157. Sontheimer RD, Gilliam JN (1978). An immunofluorescence assay for double-stranded DNA antibodies using the Crithidia luciliae kinetoplast as a double-stranded DNA substrate. J Lab Clin Med, 91(4), 550-8. (Read full article)

    Review

    1. Sontheimer RD (2009). Lichenoid tissue reaction/interface dermatitis: clinical and histological perspectives. [Review]. J Invest Dermatol, 129(5), 1088-99. (Read full article)
    2. Kuhn A, Sontheimer RD (2008). Cutaneous lupus erythematosus: molecular and cellular basis of clinical findings. [Review]. Curr Dir Autoimmun, 10, 119-40. (Read full article)
    3. Grau R, Sontheimer RD (2007). Part 1. Cutaneous cues to diagnosis of lupus. [Review]. J Musculoskelet Med, 247-263.
    4. Grau RH, Sontheimer RD (2007). Part 2. Practical guide for effective cutaneous lupus management. [Review]. J Musculoskelet Med, 23(7), 308-311.
    5. Rothfield N, Sontheimer RD, Bernstein M (2006). Lupus erythematosus: systemic and cutaneous manifestations. [Review]. Clin Dermatol, 24(5), 348-62. (Read full article)
    6. Bano S, Bombardieri S, Doria A, Iaccarino L, Lehmann P, Mosca M, Rondinone R, Sontheimer RD, Kuhn A (2006). Lupus erythematosus and the skin. [Review]. Clin Exp Rheumatol, 24(1)(suppl 40), S26-S35.
    7. Sontheimer RD, Racila E, Racila DM (2005). C1q: Its non-lytic functions in the innate and adaptive immune responses. [Review]. J Invest Dermatol, 125(1), 14-23.
    8. Sontheimer RD (2005). Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings. [Review]. Autoimmun Rev, 4(5), 253-63. (Read full article)
    9. Sontheimer RD (2005). Subacute cutaneous lupus erythematosus – A 25 year personal perspective. [Review]. Autoimmun Rev, 4(5), 253-263.
    10. Geraminejad P, DeBloom JR 2nd, Walling HW, Sontheimer RD, VanBeek M (2004). Alpha-1-antitrypsin associated panniculitis: the MS variant. [Review]. J Am Acad Dermatol, 51(4), 645-55. (Read full article)
    11. Ting WW, Vest CD, Sontheimer RD (2004). Review of traditional and novel modalities that enhance the permeability of local therapeutics across the stratum corneum. [Review]. Int J Dermatol, 43(7), 538-47. (Read full article)
    12. Sontheimer RD (2004). Skin manifestations of systemic autoimmune connective tissue disease: diagnostics and therapeutics. [Review]. Best Pract Res Clin Rheumatol, 18(3), 429-62. (Read full article)
    13. Ting W, Stone MS, Racila D, Scofield RH, Sontheimer RD (2004). Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus and the spectrum of the acute syndrome of apoptotic pan-epidermolysis (ASAP): a case report, concept review and proposal for new classification of lupus erythematosus vesiculobullous skin lesions. [Review]. Lupus, 13(12), 941-50. (Read full article)
    14. Ahmed RA, Dahl MV for the Consensus Development Group including Sontheimer RD (2003). Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases. [Review]. Arch Dermatol, 139, 1051-1059.
    15. Sontheimer RD (2002). Dermatomyositis: An overview of issues of interest to dermatologists. [Review]. Dermatol Clin, 20, 387-408.
    16. Ting WW, Sontheimer RD (2001). Local therapy for cutaneous and systemic lupus erythematosus: practical and theoretical considerations. [Review]. Lupus, 10(3), 171-84. (Read full article)
    17. Sontheimer RD (2000). : Lupus erythematosus and dermatomyositis. [Review]. Curr Probl Dermatol, 12(1), 5-8.
    18. Sontheimer RD (1999). Cutaneous features of classic dermatomyositis and amyopathic dermatomyositis. [Review]. Curr Opin Rheumatol, 11(6), 475-82. (Read full article)
    19. Sontheimer RD, Kovalchick P (1998). Cutaneous manifestations of rheumatic diseases: lupus erythematosus, dermatomyositis, scleroderma. [Review]. Dermatol Nurs, 10(2), 81-95; quiz 96-7. (Read full article)
    20. Sontheimer RD, Kovalchick P (1998). :Cutaneous manifestations of rheumatic diseases: Lupus erythematosus, dermatomyositis, scleroderma. [Review]. Dermatol Nurs, 1(02), 81-97.
    21. Sontheimer RD, Provost TT (1998). The skin in lupus — Part 2. [Review]. 18(3), 1-5.
    22. Eggleton P, Reid KB, Kishore U, Sontheimer RD (1997). Clinical relevance of calreticulin in systemic lupus erythematosus. [Review]. Lupus, 6(7), 564-71. (Read full article)
    23. Sontheimer RD (1997). The lexicon of cutaneous lupus erythematosus--a review and personal perspective on the nomenclature and classification of the cutaneous manifestations of lupus erythematosus. [Review]. Lupus, 6(2), 84-95. (Read full article)
    24. Costner M, Sontheimer RD (1997). Antimalarial therapy in photosensitive dermatoses. [Review]. Dermatol Ther, 4, 86-99.
    25. Sontheimer RD, Callen JP, Camisa C, Provost TT, Tuffanelli DL (1996). Guidelines of care for lupus erythematosus. [Review]. J Am Acad Dermatol, 34, 830-836.
    26. Sontheimer RD, Nguyen TQ, Cheng ST, Lieu TS, Capra JD (1995). The unveiling of calreticulin--a clinically relevant tour of modern cell biology. [Review]. J Investig Med, 43(4), 362-70. (Read full article)
    27. McCauliffe DP, Sontheimer RD (1993). Dermatologic manifestations of rheumatic disorders. [Review]. Prim Care, 20(4), 925-41. (Read full article)
    28. McCauliffe DP, Sontheimer RD (1993). The Ro autoantigen system. [Review]. J Invest Dermatol, 100, 73S-79S.
    29. Zappi E, Sontheimer RD (1993). Clinical relevance of antibodies to Ro(SS-A)/La(SS-B) in SCLE and related conditions. [Review]. Immunol Invest, 22(3), 189-203.
    30. Zappi E, Sontheimer RD (1993). Clinical relevance of antibodies to Ro/SS-A and La/SS-B in subacute cutaneous LE and related conditions. [Review]. Clin Dermatol, 10(4), 431-441.
    31. Sontheimer RD (1993). The skin in Sjögren's syndrome. "The Moisture Seekers" (Newsletter of the Sjögren's Syndrome Foundation). [Review]. 2&3.
    32. Sontheimer RD, Capra JD (1993). The diverse functional repertoire of calreticulin, a new human autoantigen. [Review]. 1(5), 155-160.
    33. Sontheimer RD, McCauliffe DP, Zappi E, Targoff I (1992). Antinuclear antibodies: clinical correlations and biologic significance. [Review]. Adv Dermatol, 7, 3-52; discussion 53. (Read full article)
    34. Sontheimer RD (1992). Photosensitivity in lupus erythematosus. [Review]. 12(2), 1-3.
    35. Sontheimer RD, Bergstresser PR (1991). The A, B, C's of research grant writing. The advice of two grant reviewers. [Review]. J Invest Dermatol, 97, 165-168.
    36. McCauliffe DMPM, Sontheimer RD (1991). Subacute cutaneous LE: A dozen years later. [Review]. Dermatology, 2(1), 3-4.
    37. Asherson RA, Sontheimer RD (1991). Urticarial vasculitis and syndromes in association with connective tissue disease. [Review]. Ann Rheum Dis, 50, 743-744.
    38. Sontheimer RD, McCauliffe DP (1990). Pathogenesis of anti-Ro/SS-A autoantibody-associated cutaneous lupus erythematosus. [Review]. Dermatol Clin, 8(4), 751-8. (Read full article)
    39. Sontheimer RD (1990). Subacute cutaneous lupus erythematosus. The ten year evolution of a disease concept. [Review]. 5, 3-12.
    40. Sontheimer RD (1990). Lupus erythematosus. [Review]. 24(3), 1-12.
    41. Sontheimer RD, Provost TT (1988). The skin in lupus — Part 1. [Review]. 18(2), 1-5.
    42. Siegel DM, Deng J-S, Sontheimer RD (1985). Ro/SS-A antibody associated cutaneous LE: Neonatal LE and subacute cutaneous LE. [Review]. Semin Dermatol, 4, 69-78.
    43. Sontheimer RD, Gilliam JN (1983). Subacute cutaneous lupus erythematosus. [Review]. 4, 11-17.
    44. McCauliffe DP, Sontheimer RD (1983). The Ro/SS-A autoantigen system. [Review]. J Invest Dermatol, 100, 73S-79S.
    45. Gilliam JN, Sontheimer RD (1982). Subacute cutaneous lupus erythematosus. [Review]. Clin Rheum Dis, 8(2), 343-52. (Read full article)
    46. Gilliam JN, Sontheimer RD (1982). Skin manifestations of SLE. [Review]. Clin Rheum Dis, 8(1), 207-18. (Read full article)
    47. Sontheimer RD (1982). Epidermal cell damage by immunological mechanisms. EOS. [Review]. EOS, 2, 170-176.

    Edited Book

    1. Sontheimer RD, Provost TT (Eds.) (2004). Cutaneous Manifestation of the Rheumatic Diseases. Second Edition. Philadelphia: Lippincott Williams & Wilkins.
    2. Sontheimer RD (Ed.) (2001). "The Management of Autoimmune Connective Tissue Diseases." Special issue of the journal, Dermatologic Therapy, Guest Editor.
    3. Sontheimer RD (Ed.) (1997). The Skin in Lupus Erythematosus. Special issue of the journal, Lupus. Guest editor, 6(#2):75-217.
    4. Sontheimer RD, Provost TT (Eds.) (1996). Cutaneous Manifestations of the Rheumatic Diseases. Baltimore: Williams and Wilkins.
    5. Sontheimer RD (Ed.) (1993). SCLE - Experience gained from two decades of observation. Lecture #4. Yale University/Glaxo Dermatology Lectureship Series in Dermatology. Yale University, Beechwood Associates, Inc.
    6. Sontheimer RD (Ed.) (1988). Dermatomyositis - Polymyositis. Clinics in Dermatology, Guest Editor, Vol 6, No 2. Philadelphia, PA: JB Lippincott Co.

    Book Chapter

    1. Hansen C, Fiorentino DF, Sontheimer RD (2018). Cutaneous Lupus Erythematosus (Chapter 38). In Gaspari A, Trying S (Eds.), Clinical Immunodermatology (Second Edition). Springer.
    2. Sontheimer CJ, Costner M, Sontheimer RD (2018). Lupus Erythematosus (Chapter 61). In Amagai M, Bruckner A, Enk A, Margolis D, McMichael AM, Orringer J, Kang S (Eds.), Fitzpatrick's Dermatology in General Medicine (9th Edition). New York: McGraw Hill.
    3. Sontheimer RD (2014). Approach to patients with skin manifestations. In Marco Matucci-Cerinic, David Fiorentino (Eds.), Skin Manifestations in Rheumatic Disease (pp. Chapter 1). New York: Springer.
    4. Summers EM, Sontheimer RD, Craft N, Fox LP, Goldsmith LA, Tharp MD (2014). Chronic Eczematous Eruptions of the Aged. In Web. Rochester, NY: VisualDx Visual Clinical Decision Support Tool. Available: Logical Images.
    5. Walling HW, Sontheimer RD (2012). Non-Vasculitic Cutaneous involvement (Chapter 11). In Ramos-Casals M, Stoen JH, Moutsopoulos HM (Eds.), Sjogen's Syndrome, Diagnosis and Therapeutics (pp. 157-172). London: Springer-Verlag.
    6. Costner M, Sontheimer RD (2012). Chapter 155: Lupus Erythematosus. In Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitxpatrick TB (Eds.), Fitzpatrick's Dermatology in General Medicine (8th edition). New York: McGraw Hill.
    7. Hansen CB, Sontheimer RD (2012). Chapter 156: Dermatomyositis. In Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB (Eds.), Fitzpatrick's Dermatology in General Medicine (8th edition). New York: Mc-Graw Hill.
    8. Costner MI, Sontheimer RD (2012). Lupus Erythematosus. In Lowell Goldsmith, Stephen Katz, Barbara Gilchrest, Amy Paller, David Leffell, Klaus Wolff (Eds.), Fitzpatrick's Dermatology in General Medicine (Eighth Edition, 2). New York: McGraw Hill Professional.
    9. Sontheimer RD, Hansen CB, Costner MI (2012). Dermatomyositis. In Lowell Goldsmith, Stephen Katz, Barbara Gilchrest, Amy Paller, David Leffell, Klaus Wolff (Eds.), Fitzpatrick's Dermatology in General Medicine (2, 2). New York: McGraw Hill Professional.
    10. Jacobe H, Sontheimer RD, Saxton-Daniels S (2012). Autoantibodies encountered in patients with autoimmune connective tissue disease. In Jean L. Bolognia MD, Joseph L. Jorizzo MD, Julie V. Schaffer MD (Eds.), Dermatology (Third Edition, 2). Philadelphia: Elsevier/Saunders.
    11. Sontheimer RD, Hansen, CB (2011). Diagnostic Criteria for Cutaneous Lupus Erythematosus, Chapter 6. In Maibach HI, Gorouhi F (Eds.), Evidence Based Dermatology (2nd, pp. 65-72). Shelton, CT: PMPH- USA.
    12. Sontheimer RD, Hansen C (2011). Autoimmune connective tissue diseases, Chapter 22. In Hall JC & Hall BJ (Eds.), Hall's Manual of Skin as a Marker of Underlying Disease (pp. 347-369). PMPH-USA.
    13. Sontheimer RD, Gerami P, Walling H (2008). Clinically-amyopathic dermatomyositis (Chapter 31). In Shoenfield Y, Cervera Renee, Gershwin E. (Eds.), Diagnostic Criteria for Autoimmune Diseases. Humana Press.
    14. Sontheimer RD, Gerami P, Walling HW (2008). Clinically-Amyopathic Dermatomyositis. Chapter 31. In Schoenfeld Y, Cervera R, Gershwin ME (Eds.), Diagnostic Criteria in Autoimmune Diseases. Humana Press (Springer Science).
    15. Dutz J, Sontheimer RD, Werth V (2007). Pathomechanisms of Cutaneous Lupus Erythematosus. (Chapter 29). In Hahn B, Wallace DP (Eds.), Dubois' Lupus Erythematosus (7th). Philadelphia, PA: Lippincott, William and Wilkins.
    16. Costner MI, Sontheimer RD (2007). Lupus erythematosus-nonspecific skin disease. (Chapter 31). In Hahn B, Wallace DP (Eds.), Dubois' Lupus Erythematosus (7th). Philadelphia, PA: Lippincott, William and Wilkins.
    17. McCauliffe DP, Sontheimer RD (2007). Lupus erythematosus-specific skin disease. (Chapter 30). In Hahn B, Wallace DP (Eds.), Dubois' Lupus Erythematosus (7th). Philadelphia, PA: Lippincott, William and Wilkins.
    18. Jacobe H, Sontheimer RD (2007). Autoantibodies encountered in patients with autoimmune connective tissue diseases. In Bolognia J, Jorrizo J, Mosby RR (Eds.), Dermatology (2nd). London.
    19. Costner MI, Sontheimer RD (2007). Lupus erythematosus. (Chapter 156). In Wolff K, Goldsmith L, Katz S, Gilchrest B, Paller A, Leffell D (Eds.), Dermatology in General Medicine (7th). New York: McGraw-Hill.
    20. Sontheimer RD, Costner MI (2007). Dermatomyositis. (Chapter 157). In Wolff K, Goldsmith L, Katz S, Gilchrest B, Paller A, Leffell D (Eds.), Dermatology in General Medicine (7th). New York: McGraw-Hill.
    21. Kuhn A, Sontheimer RD (2007). Cutaneous lupus erythematosus -- Molecular and cellular basis of clinical findings. In Nickoloff BJ, Nestlé F (Eds.), Current Directions in Autoimmunity: Dermatologic Autoimmunity. Krager Press.
    22. Fiorentino DF, Sontheimer RD (2007). Cutaneous lupus erythematosus. (Chapter 38). In Gaspari A, Tyring S (Eds.), Clinical Immunodermatology. Springer.
    23. Pellowski DM, Kihslinger JE, Sontheimer RD (2006). Subacute cutaneous lupus erythematosus. (Chapter 5.2). In Hurtl M (Ed.), Autoimmune Diseases of the Skin (2nd). Wien/New York: Springer Verlag.
    24. Sontheimer RD (2006). Subacute cutaneous lupus erythematosus -- a quarter century's perspective. In Puttini PS, Doria A, Girolomoni G, Kuhn A (Eds.), The Skin in Autoimmune Diseases. Handbook of Systemic Autoimmune Diseases (5). Elsevier, Amstredam.
    25. Sontheimer RD (2005). Forward. In Kuhn A, Lehmann P, Ruzicka T (Eds.), Cutaneous Lupus Erythematosus. Heidelberg: Springer Verlag.
    26. Kuhn A, Sontheimer RD, Ruzicka T (2005). Clinical manifestation of cutaneous lupus erythematosus. (Chapter 6). In Kuhn A, Lehmann P, Ruzicka T (Eds.), Cutaneous Lupus Erythematosus (pp. 59-92). Heidelberg: Springer Verlag.
    27. Costner M, Sontheimer RD, Provost TT (2004). Lupus erythematosus. (Chapter 2). In Sontheimer RD, Provost TT (Eds.), Cutaneous Manifestations of Rheumatic Diseases (2nd). Philadelphia: Lippincott, Williams and Wilkins.
    28. Sontheimer RD, Euwer R, Costner M (2004). Dermatomyositis. (Chapter 3). In Sontheimer RD, Provost TT (Eds.), Cutaneous Manifestations of Rheumatic Diseases (2nd). Philadelphia: Lippincott, Williams and Wilkins.
    29. Sontheimer RD (2004). Dermography - Richard D. Sontheimer, M.D. In Barankin B (Ed.), Dermographies - Autobiographies in Dermatology (1). Lockport, Nova Scotia: Community Books.
    30. Jacobe HT, Sontheimer RD (2003). Autoantibodies encountered in patients with autoimmune connective tissue diseases. (Chapter 42). In Bolognia J, Jorrizo J, Mosby RR (Eds.), Dermatology (1st). London.
    31. Costner M, Sontheimer RD (2003). Lupus erythematosus. (Chapter 171). In Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB (Eds.), Dermatology in General Medicine (6th). New York: McGraw-Hill.
    32. Sontheimer RD, Costner M (2003). Dermatomyositis. (Chapter 172). In Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB (Eds.), Dermatology in General Medicine (6th). New York: McGraw-Hill.
    33. Sontheimer RD, Racila D, Racila E, Eggleton P, Donnelly S (2003). Calreticulin's role(s) in autoimmune disorders. (Chapter 17). In Calreticulin (2nd). Austin: Landes Press.
    34. Sontheimer RD (2002). Cutaneous lupus. In PocketMedicine/Internal Medicine.
    35. McCauliffe DP, Sontheimer RD (2001). The cutaneous manifestations of lupus erythematosus. (Chapter 29). In Hahn B, Wallace DP (Eds.), Dubois' Lupus Erythematosus (6th). Philadelphia, PA: Lippincott, William and Wilkins.
    36. Dutz J, Sontheimer RD (2001). The pathogenesis of LE-specific skin disease. (Chapter 28). In Hahn B, Wallace DP (Eds.), Dubois' Lupus Erythematosus (6th). Philadelphia, PA: Lippincott, William and Wilkins.
    37. Pellowski D, Sontheimer RD (2001). Subacute cutaneous lupus erythematosus. In Hurtl M (Ed.), Autoimmune Diseases of the Skin. Wien/New York: Springer Verlag.
    38. Sontheimer RD (2000). Treatment of the cutaneous manifestations of autoimmune connective tissue diseases. (Chapter 19). In Millikan LE (Ed.), Drug Therapy in Dermatology (pp. 357-384). New York: Marcel Dekker Inc.
    39. Nguyen TQ, Racila D, Sontheimer RD (1999). Role of calreticulin autoimmunity in the pathogenesis of photosensitive cutaneous lupus erythematosus. In Tsokos GC, Kammer G (Eds.), Lupus Molecular and Cellular Pathogenesis (pp. 514-528). Totowa, NJ: The Humana Press.
    40. Sontheimer RD (1998). Autoimmune connective tissue disorders. In Rakel RE (Ed.), Conn's Current Therapy (pp. 791-796). WB Saunders.
    41. Euwer RL, Sontheimer RD (1998). Dermatomyositis. In Demis' Clinical Dermatology. Lippincott.
    42. Sontheimer RD (1998). Cutaneous lupus erythematosus. In Jameson JL (Ed.), Principles of Molecular Medicine (pp. 821-827). Totowa, NJ: Humana Press.
    43. Sontheimer RD, Provost TT (1997). Cutaneous manifestations of lupus erythematosus (Chapter 34). In Wallace DJ, Hahn BH (Eds.), Dubois' Lupus Erythematosus (5th, pp. 569-627). Baltimore, MD: Williams & Wilkins.
    44. Sontheimer RD, Nguyen TQ, Cheng ST, Lieu TS, Capra JD (1996). Calreticulin and autoimmunity (Chapter 8). In Michalak M (Ed.), Calreticulin. RG Landers Co, Biomedical Publishers.
    45. Sontheimer RD, Provost TT (1996). Lupus erythematosus (Chapter 1). In Sontheimer RD, Provost TT (Eds.), Cutaneous Manifestations of the Rheumatic Diseases. Baltimore, MD: Williams & Wilkins.
    46. Euwer RL, Sontheimer RD (1996). Dermatomyositis (Chapter 2). In Sontheimer RD, Provost TT (Eds.), Cutaneous Manifestations of the Rheumatic Diseases. Baltimore, MD: Williams & Wilkins.
    47. McCauliffe DP, Sontheimer RD (1996). Management of cutaneous LE. In Schur PH (Ed.), The Clinical Management of Systemic Lupus Erythematosus (2nd). New York, NY: Grune and Stratton.
    48. Sontheimer RD, Tharp MD (1993). The immunological repertoire of the dermal microvascular unit (Chapter 7). In Nickoloff BJ (Ed.), Dermal Immune System. Boca Raton, FL: CRC Press.
    49. Sontheimer RD (1993). Management of refractory cutaneous LE. In Klippel JH, Dieppe P (Eds.), Rheumatology. London, England: Gower Medical Publishing.
    50. Sontheimer RD (1993). Lupus erythematosus (Chapter 172). In Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB (Eds.), Dermatology in General Medicine (5th). New York: McGraw-Hill.
    51. Sontheimer RD, Euwer RL, Geppert T, Cohen S, Moschella SL (1992). Connective Tissue Diseases (Chapter 50). In Moschella SL (Ed.), Dermatology (3rd). Philadelphia, PA: WB Saunders Co, Ltd, East Sussex.
    52. Sontheimer RD, Gilliam JN (1992). SLE and the skin (Chapter 28). In Lahita RG (Ed.), Systemic Lupus Erythematosus (2nd). New York, NY: Wiley Medical Publications.
    53. McCauliffe DP, Sontheimer RD (1992). Subacute cutaneous lupus erythematosus (Chapter 31). In Wallace DJ, Hahn B (Eds.), Dubois' Lupus Erythematosus (4th). Philadelphia, PA: Lea and Febiger.
    54. Sontheimer RD (1992). Clinical manifestations of cutaneous lupus erythematosus (Chapter 30). In Wallace DJ and Hahn B (Eds.), Dubois' Lupus Erythematosus (4th). Philadelphia, PA: Lea and Febiger.
    55. Sontheimer RD, Provost TT (1991). Lupus Erythematosus (Chapter 30). In Jordon RE (Ed.), Immunologic Diseases of the Skin, Appleton and Lange. East Norwalk, CT.
    56. Sontheimer RD, Zappi E, McCauliffe DP (1991). Antinuclear antibodies: Clinical correlations and biological significance. In Advances in Dermatology (7, pp. 3-52).
    57. Euwer RL, Sontheimer RD, Braverman I (1990). Dermatomyositis and polymyositis. 17th Revision, Chapter 5-4. In Demis DJ (Ed.), Clinical Dermatology (1). Philadelphia, PA: JB Lippincott Co.
    58. Sontheimer RD, Fine JD (1990). Biology of the dermoepidermal interface and the pathophysiology of bullous pemphigoid, epidermolysis bullosa acquisita, and lupus erythematosus (Chapter 19). In Soter NA, Baden HP (Eds.), Pathophysiology of Dermatologic Disease (2nd). New York, NY: McGraw-Hill.
    59. Sontheimer RD (1988). Lupus Erythematosus (Chapter 35). In Greer KE (Ed.), Common problems in Dermatology: Recommendations of the Experts. Chicago, IL: Year Book Medical Publishers.
    60. Sontheimer RD (1988). Lupus Erythematosus. In Provost TT, Farmer ER (Eds.), Current Therapy in Dermatology-2 (pp. 123-128). Philadelphia, PA: BC Decker, Inc.
    61. Sontheimer RD (1988). Comparison of the clinical, histological and immunogenetic features of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus (Discoid LE). In Orfanos CE, Stadler R and Gollnick H (Eds.), Dermatology in Five Continents: Proceedings of the XVII World Congress of Dermatology (pp. 254-259). Berlin: Springer-Verlag.
    62. Sontheimer RD, Rothfield N, Gilliam JN (1986). Lupus erythematosus (Chapter 152). In Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF (Eds.), Dermatology in General Medicine (3rd). McGraw Hill.
    63. Sontheimer RD (1985). Subacute cutaneous lupus erythematosus (Chapter 6). In Callen J (Ed.), Clinics in Dermatology (3, pp. 58-68). Philadelphia, PA: JB Lippincott Co.
    64. Sontheimer RD (1984). Lupus erythematosus. In Rakel RE (Ed.), Conn's Current Therapy (pp. 630-637). WB Saunders Co.
    65. Gilliam JN, Cohen S, Sontheimer RD, Moschella SL (1984). Connective tissue diseases (Chapter 18). In Moschella SL (Ed.), Dermatology (2nd, 2). Philadelphia, PA: WB Saunders Co Ltd.
    66. Gilliam JN, Sontheimer RD (1984). Clinically and immunologically defined subsets of lupus erythematosus. In Fleischmajer R (Ed.), Progress in Diseases of the Skin (2). San Diego, CA: Grune & Stratton, Inc.
    67. Sontheimer RD, Gilliam JN (1983). Subacute cutaneous lupus erythematosus. Proceedings of XVI International Congress of Dermatology. In Kukita A, Seigi M (Eds.). Tokyo, Japan: University of Tokyo Press.

    Conference Proceedings

    1. Ruperto N, Hanrahan LM, Alarcon GS, Belmont HM, Brey RL, Brunetta P, Buyon JP, Costner MI, Cronin ME, Dooley MA, Filocamo G, Fiorentino D, Fortin PR, Franks AG Jr, Gilkeson G, Ginzler E, Gordon C, Grossman J, Hahn B, Isenberg DA, Kalunian KC, Petri M, Sammaritano L, Sanchez-Guerrero J, Sontheimer RD, Strand V, Urowitz M, von Feldt JM, Werth VP, Merrill JT (2011). International consensus for a definition of disease flare in lupus. Lupus, England, 20(5), 453-62. (Read full article)

    Case Report

    1. Logan S, Sontheimer R (2019). Concurrence of erythema elevatum diutinum and HIV infection: A case report and literature review. JAAD Case Rep, 5(12), 1093-1096. (Read full article)
    2. Brummer GC, Wang LT, Sontheimer RD (2018). A possible role for dupilumab (Dupixent) in the management of idiopathic chronic eczematous eruption of aging. pii:13030/qt55zlf6xh. PubMed PMID: 29630150. Dermatol Online J, 24(2).
    3. Li Y, Foshee JB, Sontheimer RD (2011). Sustained clinical response to rituximab in case of life-threatening overlap subepidermal autoimmune blistering disease. J Am Acad Dermatol, 64(4), 773-778.
    4. Henderson CL, Lafleur L, Sontheimer RD (2008). Sarcoidal alopecia as a mimic of discoid lupus erythematosus. J Am Acad Dermatol, 59(1), 143-5. (Read full article)
    5. Geraminejad PA, Walling HW, Swick BL, Sontheimer RD (2004). Chronic penile ulceration in a 72-year-old man. Arch Dermatol, 140(7), 877-82. (Read full article)
    6. Geraminejad P, Stone MS, Sontheimer RD (2004). Antimalarial lichenoid tissue reactions in patients with pre-existing lupus erythematosus. Lupus, 13(6), 473-7. (Read full article)
    7. Pandya AG, Sontheimer RD (1992). Treatment of pemphigus vulgaris with pulse intravenous cyclophosphamide. Arch Dermatol, 128(12), 1626-30. (Read full article)
    8. Pandya A, Sontheimer RD (1992). Pulse intravenous cyclophosphamide in the management of pemphigus vulgaris. Arch Dermatol, 128, 1626-1630.
    9. Cruz PD, Sontheimer RD (1987). Concurrent features of cutaneous lupus erythematosus and pemphigus erythematosus following myasthenia gravis and thymoma. J Am Acad Dermatol, 16, 472-480.
    10. Cohen S, Stastny P, Sontheimer RD (1985). Concurrence of rheumatoid arthritis and subacute cutaneous lupus erythematosus. Arthritis Rheum, 29, 421-425.
    11. Sontheimer RD, Garibaldi RA, Krueger GG (1978). Stevens-Johnson syndrome associated with Mycoplasma pneumoniae infections. Arch Dermatol, 114(2), 241-4. (Read full article)
    12. Hales G, Sontheimer RD, et al (1972). Wound botulism. MMWR Recomm Rep, 21, 144-423.

    Editorial

    1. Sontheimer RD, Connolly MK, Fiorentino DF, Werth VP (2021). Why rheumatologic skin disease? Ann Transl Med, 9(5), 428. (Read full article)
    2. Sontheimer RD (2017). When your medication backfires and calls in the wolves. Atlas of Science (https://atlasofscience.org/when-your-medication-backfires-and-calls-in-the-wolves/).
    3. Sontheimer RD, McBride JD (2017). Fingernails: A Window into the World of Disease. Atlas of Science (http://atlasofscience.org).
    4. Sontheimer RD (Sept. 2010). Meeting Report- North American Rheumatologic Dermatology Society. Arch Dermatology, 146(9), 999.
    5. Sontheimer RD (2010). Clinically amyopathic dermatomyositis: what can we now tell our patients? Arch Dermatol, 146(1), 76-80. (Read full article)
    6. Sontheimer RD (2008). Multitasking – A photoessay. Northwest Style Magazine, Oklahoma City, OK. Southwestern Publishing, 3(4), 104.
    7. Sontheimer RD (2007). Desensitization to hydroxychloroquine: alternative interpretations. J Rheumatol, 34(2), 253-5; discussion 255. (Read full article)
    8. Sontheimer RD (2005). The cost of medical care: Then (1700 B.C.) and now. 1(3), a6.
    9. Oddis C, t al, Sontheimer RD (2005). International consensus guidelines for therapeutic trials in the idiopathic inflammatory myopathies. Arthritis Rheum, 52(9), 2607-15.
    10. Sontheimer RD (2004). Dermentigree – Richard D. Sontheimer, M.D. 3(2), a6.
    11. Sontheimer RD (2003). What will I say to Mr. C.J.? 4(1), a12.
    12. Sontheimer RD (2003). The question of personal financial support of the Dermatology Foundation: Evolution of perspective of a full-time academic, Part 2. Association of Professors of Dermatology Newsletter.
    13. Sontheimer RD (2002). The question of personal financial support of the Dermatology Foundation: Evolution of perspective of a full –time academic, Part 1. Association of Professors of Dermatology Newsletter.
    14. Sontheimer RD (2000). Questions answered and a $1 million question raised concerning lupus erythematosus tumidus: is routine laboratory surveillance testing during treatment with hydroxychloroquine for skin disease really necessary. Arch Dermatol, 136(8), 1044-9. (Read full article)
    15. Sontheimer RD (1997). Report from the Medical Dermatology Society. Dermatology Online Journal, 3, 9-11.
    16. Sontheimer RD (1996). The Medical Dermatology Society. Arch Dermatol, 132, 1373-1374.
    17. Sontheimer RD (1993). Antibodies inside our keratinocytes? Arch Dermatol, 129(9), 1184-7. (Read full article)
    18. Sontheimer RD, Bergstresser PR (1991). The ABCs of research grant writing: the advice of two grant reviewers. J Invest Dermatol, 97(2), 165-8. (Read full article)
    19. Sontheimer RD (1985). Immunobiological significance of the Ro/SSA antigen-antibody system. Arch Dermatol, 121(3), 327-30. (Read full article)

    Letter

    1. Sontheimer RD (2014). Skin is not the largest organ. [Letter to the editor]. J Invest Dermatol, 134(2), 581-582. (Read full article)
    2. Sontheimer, RD (2010). "Unbent, Unbroken." Hektoen International. [Letter to the editor]. J Med Humanit, 2(3).
    3. Sontheimer RD (2008). Tip 4: Making the correct diagnosis for lupus, dermatomyositis and scleroderma. Clinical Tip [Letter to the editor]. 43.
    4. Sontheimer R (2006). A father’s day of golf [Letter to the editor]. 4(2).
    5. Sontheimer R (2006). The Stars in my sky are flickering out [Letter to the editor]. 4(1).
    6. Sontheimer RD, Ellis UM (2005). Out-of-pocket prescription costs: a suggestion. [Letter to the editor]. Arch Intern Med, 165(20), 2430. (Read full article)
    7. Sontheimer RD (2005). The cost of medical care: Then (1700 B.C.) and now. Response to Dr. Carlos Garcia [Letter to the editor]. 3(2).
    8. Sontheimer RD (2005). Differentiation of subacute cutaneous lupus erythematosus from clinically-amyopathic dermatomyositis [Letter to the editor]. 15.
    9. Sontheimer RD, Miyagawa S (2003). Potentially fatal interstitial lung disease can occur in clinically amyopathic dermatomyositis. [Letter to the editor]. J Am Acad Dermatol, 48(5), 797-8. (Read full article)
    10. Sontheimer RD (2002). Relative risk-A near fatal case of acne. http://ojcpcd.com/sontheimer-r-d/relative-risk-a-near-fatal-case-of-acne-richard-d-sontheimer/ [Letter to the editor].
    11. Sontheimer RD (2002). A chance meeting of two arthritis patients at the arthritis meeting. Letter to the editor [Letter to the editor]. 46(6), 1697-1698.
    12. Werth VP, Sontheimer RD, Piette WW, Lee LA (1998). The proper future for medical dermatology. [Letter to the editor]. Arch Dermatol, 134(9), 1159-60, 1161-2. (Read full article)
    13. Sontheimer RD, Houpt KR (1998). DIDMOHS: a proposed consensus nomenclature for the drug-induced delayed multiorgan hypersensitivity syndrome. [Letter to the editor]. Arch Dermatol, 134(7), 874-6. (Read full article)
    14. Zieglschmid-Adams ME, Pandya A, Cohen SB, Sontheimer RD (1998). The value of methotrexate in dermatomyositis. [Letter to the editor]. J Am Acad Dermatol, 38(1), 130-2. (Read full article)
    15. Costner MI, Sontheimer RD (1995). Osteoarthritis in 84 Japanese patients with palmoplantar pustulosis. [Letter to the editor]. J Am Acad Dermatol, 33(3), 543. (Read full article)
    16. Sontheimer RD (1993). Greenwald's law of lupus: the Sontheimer amendment. [Letter to the editor]. J Rheumatol, 20(7), 1258-9. (Read full article)
    17. Sontheimer RD (1993). Fluorescent light photosensitivity in patients with systemic lupus erythematosus: comment on the article by Rihner and McGrath. [Letter to the editor]. Arthritis Rheum, 36(3), 428-31. (Read full article)
    18. Sontheimer RD, Euwer R (1992). Amyopathic dermatomyositis [Letter to the editor]. J Am Acad Dermatol, 26, 506-508.
    19. Sontheimer RD (1991). Another view concerning the proposal to change the name of the American Academy of Dermatology. [Letter to the editor]. Arch Dermatol, 127(9), 1416. (Read full article)
    20. Milewich L, Sontheimer RD (1989). Steroid hormone metabolism by human epidermal keratinocytes. [Letter to the editor]. J Invest Dermatol, 93(2), 292. (Read full article)
    21. Sontheimer RD (1988). What If? [Letter to the editor]. J Am Acad Dermatol, 18(2, P1), 25A.
    22. Sontheimer RD (1988). Festschrift to Professor James N. Gilliam. Chapter 1. Dermatomyositis-Polymyositis. JB Lippincott Co, Philadelphia, PA [Letter to the editor]. Clin Dermatol.
    23. Roberts LJ, Sontheimer RD (1986). Neonatal lupus erythematosus [Letter to the editor]. Pediatr Dermatol, 3, 417-418.
    24. Sontheimer RD, Gilliam JN (1983). An immunologic basis for annular skin lesions [Letter to the editor]. Ann Intern Med, 98, 557-558.
    25. Sontheimer RD, Gilliam JN (1982). Membrane attack complex in lupus erythematosus skin lesions. [Letter to the editor]. N Engl J Med, 307(2), 124-5. (Read full article)

    Abstract

    1. LaFleur L, Lovelace K, Roberts DN, Sontheimer R (2008). Anti-epiligrin negative paraneoplastic mucous membrane pemphigoid (poster 1502). AD824 [Abstract]. J Am Acad Dermatol.
    2. LaFleur L, Lovelace K, Sontheimer RD, John M (2007). Pemphigus erythematosus presenting as a mimic of seborrheic dermatitis. American Academy of Dermatology Annual Meeting [Abstract].
    3. Metcalf SK, Kuykendall T, Prasertsuntarasai T, Targoff IN, Sontheimer RD (2007). Familial amyopathic dermatomyositis with spontaneous remission during pregnancy: A case series and review of concepts. American Academy of Dermatology Annual Meeting [Abstract].
    4. Quain RD, Bangert CC, Costner M, Connolly KK, Dugan E, Okawa J, Rose M, Rosenbach M, Fakharzadeh SS, Fiorentino D, Lee LA, Sontheimer RD, Taylor L, Werth VP (2007). The CDASI (Cutaneous Dermatomyositis Disease Area and Severity Index), DSSI (Dermatomyositis Skin Severity Index) and CAT (Cutaneous Assessment Tool): Comparison of inter- and intra-rater reliability and validity in the development of an outcome instrument for dermatomyositis [Abstract]. J Invest Dermatol, 127, S59.
    5. Sontheimer RD (2007). Lichenoid tissue reaction/interface dermatitis: Clinical and histological perspectives. Presented at the Montagna Symposium on the Biology of Skin. Epidermal Cell-T Cell Interactions [Abstract].
    6. Quain RD, Bangert CC, Costner M, Connolly KK, Dugan E, Tanikawa A, Okawa J, Rose M, Fakharzadeh SS, Fiorentino D, Lee LA, Sontheimer RD, Taylor L, Werth VP (2007). The development element of an outcome instrument for cutaneous dermatomyositis: Comparison of inter- and intra-rater reliability and validity [Abstract]. Arthritis Rheumat, 56(#9 suppl), S788.
    7. LaFleur L, Kuykendall T, Crowson AN, Sontheimer RD (2006). Vesiculo-bullous systemic lupus erythematosus in a four old girl presenting as mixed bullous dermatosis of childhood. Poster presentation. American Academy of Dermatology annual meeting [Abstract].
    8. VanBeek M, Sontheimer RD (2005). Quality of life and health utility assessment in dermatomyositis [Abstract]. J Invest Dermatol, 124, A56.
    9. Pickering MC, Rose K, Botto M, Sontheimer RD (2005). C1q is not required for the induction and elicitation of murine allergic contact dermatitis [Abstract]. J Invest Dermatol, 124, A117.
    10. Racila M, Racila E, Sontheimer RD (2004). Etradiol and the C1qA G288>A (AF 135157) exonic single nucleotide polymorphism control SC35 splicing factor activity in the processing of C1qA pre-mRNA. (abstract #074) [Abstract]. J Invest Dermatol, 122(3), A13.
    11. Sontheimer RD, Wu Q (2004). Inhibition of lymphotoxin signaling blocks the clinical expression of murine graft versus host skin disease by altering the microenvironment within secondary lymphoid organs [Abstract]. J Invest Dermatol, 122(3), A125.
    12. Racila D, Sontheimer RD (2003). BDCA-2 and CD91 are co-expressed in skin lesions of subacute cutaneous lupus erythematosus (LE), discoid LE, and dermatomyositis [Abstract]. J Invest Dermatol, 121(0067).
    13. Wu Q, Sontheimer RD (2003). Blockade of lymphotoxin signaling inhibits the clinical expression of murine graft versus host skin disease [Abstract]. J Invest Dermatol, 121(0910).
    14. Ting WW, Schultz K, Peterson M, Vest C, Sontheimer RD (2003). Correlation of Breslow depth of melanoma and extent of tanning bed exposure as a measure of dose-response relationship? [Abstract]. J Invest Dermatol, 121(0431).
    15. Schultz K, Ting WW, Peterson M, Vest C, Sontheimer RD (2003). Risk of melanoma is associated with tanning bed exposure, particularly among young females [Abstract]. J Invest Dermatol, 121(0433).
    16. Ting WW, Vest C, Sontheimer RD (2003). Differences in the perceptive importance and personal practice of sun protection among primary care physicians are reflected in their clinical practice [Abstract]. J Invest Dermatol, 121(0442).
    17. Racila D, Sontheimer RD (2002). The autoantibody response to human calreticulin displays features of a non-classical heat shock protein autoimmune response [Abstract]. J Invest Dermatol, 119(686).
    18. Sontheimer RD, Sontheimer CJ, Sheffield A, Racila E, Racila D (2002). Homozygous variant of the complement C1qA gene associated with subacute cutaneous lupus erythematosus [Abstract]. J Invest Dermatol, 119(687).
    19. Vest C, Ting W, Sontheimer RD (2002). Prevalence of tanning bed usage and associated behaviors [Abstract]. J Invest Dermatol, 119(244).
    20. Racila M, Sontheimer CJ, Sheffield A, Racila E, Sheffield V, Sontheimer RD (2002). Homozygous genetic variant of complement C1q A gene is associated with subacute cutaneous lupus erythematosus. 20th World Congress of Dermatology, Paris [Abstract].
    21. Sontheimer RD, Racila D (2001). Blood levels of soluble vascular adhesion molecules, VCAM-1 and E-selectin are increased in clinically-amyopathic dermatomyositis [Abstract]. J Invest Dermatol.
    22. Racila D, Sontheimer RD (2000). Spontaneous development of skin lesions having features of cutaneous lupus erythematosus in mice undergoing DNA antibody 16/6 idiotype-induced autoimmunity [Abstract]. J Invest Dermatol, 114, 874.
    23. Targoff I, Sontheimer RD (2000). Autoantibodies to 155 kD and Se autoantigens in patients with clinically-amyopathic dermatomyositis [Abstract]. Arthritis Rheumatol, 43, S194.
    24. Racila D, Sontheimer RD (1999). C1q inhibits autoantibody binding to calreticulin. Society for Investigative Dermatology [Abstract].
    25. Racila D, Sontheimer RD (1999). C1q inhibits autoantibody binding to calreticulin [Abstract]. FASEB J, 12, A608.
    26. Sontheimer RD (1998). The evolving concept of amyopathic dermatomyositis. Dermatology 2000 — Singapore Congress Proceedings [Abstract].
    27. Sontheimer RD, Yang Y-S, Nguyen TQ, Capra JD (1996). Calreticulin binds directly to the 52 KD Ro/SS-A polypeptide autoantigen in-vivo [Abstract]. J Invest Dermatol, 106, 938.
    28. Sontheimer RD, Nguyen TQ, Buyon JP, Lee LA, Hall RP, Yang Y-S, Capra JD (1996). Clinical correlations of autoantibodies to a recombinant, hYRNA-binding form of human calreticulin [Abstract]. J Invest Dermatol, 106, 938.
    29. Denfeld RW, Weiss JM, Voith U, Mal B, Kind P, Sontheimer RD, Schpf, Simon JC (1996). In situ expression of B7 and CD28 receptor families in skin lesions of patients with lupus erythematodes [Abstract]. J Invest Dermatol, 106, 926.
    30. Kind P, Lipsky PE, Sontheimer RD (1995). Circulating T & B cell abnormalities in cutaneous lupus erythematosus [Abstract]. Clin Res, 33, 655A.
    31. Nguyen TQ, Capra JD, Sontheimer RD (1995). Localization of the stress response motif within the human calreticulin promoter [Abstract]. J Invest Dermatol, 104(4).
    32. Lieu TS, Sontheimer RD (1995). Autoantibody- and hYRNA-binding properties of calreticulin [Abstract]. J Invest Dermatol, 104(4).
    33. Cheng S-T, Nguyen TQ, Capra JD, Sontheimer RD (1995). Recombinant calreticulin binds specifically to synthetic hYRNA [Abstract]. J Invest Dermatol, 104(4).
    34. Ono M, Tucker PW, Sontheimer RD, Ueki H, Capra JD (1995). The KU autoantigen inhibits transcription of free-end DNA fragments [Abstract]. J Invest Dermatol, 104(5).
    35. Nguyen TQ, Capra JD, Sontheimer RD (1994). Aminoquinoline antimalarials modulate UV-induced C-jun activation in A431 cells [Abstract]. J Invest Dermatol, 102, 540.
    36. Lieu TS, Zappi E, Capra JD, Sontheimer RD, Ghebrehiwet B, Eggleton P, Sastry Kedar, Tauber A (1994). The human C1q receptor and calreticulin share cross-reactive epitopes [Abstract]. J Invest Dermatol, 102, 590.
    37. Lieu TS, Zappi E, Capra JD, Sontheimer RD, Nakhasi H (1994). An autoantigenic form of human calreticulin is an hY RNA and rubella RNA binding protein [Abstract]. J Invest Dermatol, 102, 590.
    38. Pandya AG, Sontheimer RD, Cockerell CJ, Takashima A, Piepkorn M (1994). Glycosaminoglycan production is upregulated in fibroblasts derived from papulonodular mucinosis lesions in SLE [Abstract]. J Invest Dermatol, 102, 575.
    39. Nguyen TQ, Capra JD, Sontheimer RD (1993). Calreticulin (CR) is transcriptionally regulated by heat shock [Abstract]. Clin Res, 41, 443A.
    40. Ono M, Tucker P, Sontheimer RD, Capra JD (1993). Characterization of the heterodimeric human Ku autoantigen using baculovirus [Abstract]. Clin Res, 41, 471A.
    41. Lieu TS, Sontheimer RD (1993). A subpopulation of Wil-2 cell calreticulin (CR) molecules are found within Ro/SS-A ribonucleoprotein particles (RNP) [Abstract]. Clin Res, 41, 470A.
    42. Lieu TS, Capra JD, Sontheimer RD, Nakhasi HL (1993). An autoantigenic form of human calreticulin is an hY RNA and rubella RNA binding protein [Abstract]. Arthritis Rheum, 36(9), S241.
    43. Lieu TS, Zappi E, Capra JD, Sontheimer RD, Ghebrehiwet B, Eggleton P, Sastry K, Tauber A (1993). The human C1q receptor and calreticulin share cross-reactive epitopes [Abstract]. Arthritis Rheum, 36(9), S241.
    44. Kawashima T, Lieu TS, Capra JD, Sontheimer RD (1992). Ultraviolet irradiation preferentially upregulates expression of the 46 kD Ro/SS-A autoantigen (calreticulin) in transformed human epidermal keratinocytes [Abstract]. Clin Res, 40, 508A.
    45. Sontheimer RD, McCauliffe DP, Wilson JL, Capra JD (1992). Transcriptional regulation of human calreticulin [Abstract]. Clin Res, 40, 493A.
    46. Lieu TS, Capra JD, Sontheimer RD (1992). Calreticulin is a component of the human Wil-2 cell Ro/SS-A autoantigen complex [Abstract]. Clin Res, 40, 508A.
    47. Lieu TS, Capra JD, Sontheimer RD (1992). Calreticulin is a component of the human Wil-2 cell Ro/SS-A autoantigen complex [Abstract]. Arthritis Rheum, 35(suppl), S172.
    48. Lieu T-S, Harley JB, Craft JE, Capra JD, Sontheimer RD (1991). Molecular interaction between human calreticulin and the 60 kD Ro/SS-A autoantigen [Abstract]. Clin Res, 39, 322A.
    49. McCauliffe DP, Yang Y-S, Sontheimer RD, Capra JD (1991). Characterization of the promoter region of human calreticulin (the 46 kD Ro/SS-A autoantigen) [Abstract]. Clin Res, 39, 481A.
    50. Zappi EG, McCauliffe DP, Hasemann CA, Lieu TS, Sontheimer RD, Capra JD (1991). Expression of the human 46 kD Ro/SS-A autoantigen (calreticulin) as a recombinant protein [Abstract]. Clin Res, 39, 496A.
    51. Lieu TS, Michalak M, Capra JD, Sontheimer RD (1991). Characterization of the autoantibody- and calcium-binding domains of human calreticulin (the 46 kD Ro/SS-A autoantigen) [Abstract]. Clin Res, 39, 507A.
    52. Kaminski MJ, Cruz Jr PD, Takashima A, Sontheimer RD, Bergstresser PR (1991). Human dermal microvascular endothelial cells (DMVEC) are a sensitive target for phototoxicity in vitro [Abstract]. Clin Res, 39.
    53. Simon JC, Cruz PD Jr, Sontheimer RD, Tigelaar RE, Bergstresser PR (1990). The adhesion molecules CD11a, CD18, and ICAM-1 on human epidermal Langerhans cells (LC) serve a functional role in the activation of alloreactive T cells [Abstract]. Clin Res, 38, 620A.
    54. Lieu T-S, McCauliffe DP, Volpe P, Alderson-Lang BH, Michalak M, Capra JD, Sontheimer RD (1990). Structural and functional homology between a human Ro/SS-A (Ro) autoantigen and the calcium binding protein (CBP), Calreticulin (CR) [Abstract]. Clin Res, 38, 408A.
    55. McCauliffe DP, Lieu T-S, Kennedy T, Sontheimer RD, Capra JD (1990). A Human Ro/SS-A (Ro) Autoantigen is the human homologue of murine Calreticulin, Onchocercal Ral-1 antigen, and aplysia protein 407 [Abstract]. Clin Res, 38, 631A.
    56. Zappi E, McCauliffe DP, Sontheimer RD, Capra JD (1990). Cloning and sequencing of the Drosophila homologue of a human Ro/SS-A (Ro) autoantigen [Abstract]. Clin Res, 38, 633A.
    57. Lux FA, McCauliffe DP, Buttner DW, Capra JD, Sontheimer RD, Lieu T-S (1990). Antibodies to onchocerca volvulus cross-react with a human Ro/SS-A autoantigen [Abstract]. Clin Res, 38, 626A.
    58. Lieu T-S, McCauliffe DP, Lee LA, Norris DN, Capra JD, Sontheimer RD (1990). Variant epitope binding profile of drug-induced Ro/SS-A autoantibodies [Abstract]. Clin Res, 38, 631A.
    59. Sontheimer RD, Simon JC, Thiele DL (1990). L-Leucyl-L-Leucine-O-Methyl ester pretreatment inhibits the mixed epidermal cell-lymphocyte reaction [Abstract]. Clin Res, 38, 642A.
    60. Sontheimer RD, McCauliffe DP, Michalak M, Capra JD, Lieu T-S (1990). Cytoplasmic localization of a calcium-binding 46 kD human Ro/SS-A autoantigen [Abstract]. Arthritis Rheum, 33((suppl)), S74.
    61. Zappi EG, McCauliffe DP, Hasemann CA, Sontheimer RD, Capra JD (1990). Expression of the human 46 kD Ro/SS-A autoantigen (calreticulin) as a recombinant protein [Abstract]. Clin Res, 38, 962A.
    62. Kaminski MJ, Sontheimer RD, Bergstresser PR, Cruz PD (1990). Human dermal microvascular endothelial cells are a target of PUVA-induced phototoxicity in vitro [Abstract]. Clin Res, 38, 962A.
    63. McCauliffe DP, Lieu T-S, Sanz I, Hanke J, Newkirk M, Capra JD, Sontheimer RD (1989). Immunological and molecular genetic studies of the Ro/SS-A polypeptide [Abstract]. Clin Res, 37, 79A.
    64. Lieu T-S, McCauliffe DP, Capra JD, Sontheimer RD (1989). Structure and epitope study of human Ro/SS-A antigen [Abstract]. FASEB J, 3, A491(1542).
    65. Lieu T-S, McCauliffe DP, Arnett FC, Lee LA, Deng J-S, Capra JD, Sontheimer RD (1989). Epitope mapping of the human Wil-2 cell Ro/SS-A autoantigenic polypeptide [Abstract]. Clin Res, 37, 662A.
    66. McCauliffe DP, Lieu T-S, Capra JD, Sontheimer RD (1989). The genomic configuration of a human Ro/SS-A gene [Abstract]. Clin Res, 37, 758A.
    67. Lieu T-S, Sontheimer RD (1989). Photo-modulation of the human Wil-2 cell Ro/SS-A antigenic protein [Abstract]. Clin Res, 37, 352A.
    68. Sontheimer RD (1989). Normal human dermis contains a constitutive, highly-efficient alloantigen-presenting cell [Abstract]. Clin Res, 37, 653A.
    69. Sontheimer RD (1988). Isolation and preliminary functional characterization of dermal macrophages (MP) from newborn human foreskin [Abstract]. Clin Res, 36, 696A.
    70. McCauliffe DP, Lieu T-S, Sontheimer RD (1988). An enzyme-linked immunosorbent assay (ELISA) inhibition technique for quantifying Ro/SS-A antigen in skin and other types of human tissue [Abstract]. Clin Res, 36, 673A.
    71. Lieu T-S, McCauliffe DP, Sanz I, Hanke J, Newkirk MM, Capra JD, Sontheimer RD (1988). Structural, immunological and molecular genetic studies of the Ro/SS-A polypeptide [Abstract]. Clin Res, 36, 377A.
    72. Lee LA, Sontheimer RD, Coulter SN (1988). Lupus panniculitis sera contain autoantibodies to a 30 KD protein [Abstract]. Clin Res, 36(377A).
    73. Lieu T-S, Newkirk MM, Arnett FC, Lee LA, Deng J-S, Capra JD, Sontheimer RD (1988). A major epitope is present on the amino terminus of the human Ro/SS-A (Ro) polypeptide [Abstract]. Clin Res, 36, 668A.
    74. Nguyen TQ, Black A, Zappi E, Nguyen D, Sontheimer RD (1988). Subacute cutaneous lupus erythematosus: interim analysis of long-term prospective follow-up study [Abstract]. J Invest Dermatol.
    75. Lieu T-S, Arnett FC, Sontheimer RD (1987). Comparison of the autoimmune response to Ro/SS-A (Ro) antigen in patients (PTS) with Sjögren syndrome (SS) and subacute cutaneous lupus erythematosus (SCLE) [Abstract]. Clin Res, 35, 700A.
    76. Sontheimer RD, Ziff M, Cavender D (1987). Impact of UV-B irradiation on binding of lymphoid cells (LC) to endothelial cells (EC) [Abstract]. Clin Res, 35, 719A.
    77. Lieu T-S, Newkirk M, Capra JD, Sontheimer RD (1987). Amino terminal sequence of the protein which bears the human Ro/SS-A (Ro) antigen [Abstract]. Clin Res, 35, 388A.
    78. Sontheimer RD, Cavender D, Haskard DO, Geppert TD, Ziff M (1987). Comparison of the immunobiological properties of dermal microvascular endothelial cells (DMEC) and umbilical vein endothelial cells (UVEC) [Abstract]. Clin Res, 35, 391A.
    79. Fleck R, Geppert TD, Sontheimer RD (1986). Gamma-interferon induction of class II surface antigens on cultured human dermal microvascular endothelial cells [Abstract]. Clin Res, 34, 749A.
    80. Sontheimer RD, Matsubara T (1986). Immunological phenotype of a human dermal perivascular dendritic cell [Abstract]. Clin Res, 34, 419A.
    81. Davis T, Lyde C, Davis BM, Sontheimer RD (1986). Perturbation of experimental UV-B induced erythema by passive transfer of serum from subacute cutaneous lupus erythematosus patients [Abstract]. Clin Res, 34, 745A.
    82. Lieu T-S, Reimer CB, Sontheimer RD (1986). Characterization of the autoimmune response to Ro/SS-A antigen in patients with subacute cutaneous lupus erythematosus by enzyme-linked immunosorbent assay analysis [Abstract]. Clin Res, 34, 763A.
    83. Sontheimer RD, Callen JP, Stelzer JP, Kulich KB, Lieu T-S (1986). Circulating anti-Ro/SS-A antibodies in patients with discoid lupus erythematosus [Abstract]. Clin Res, 34, 782A.
    84. Purcell SM, Lieu TS, Davis BM, Sontheimer RD (1985). Relationship between circulating anti-Ro/SS-A antibody levels and skin disease activity in subacute cutaneous lupus erythematosus [Abstract]. Clin Res, 33, 677A.
    85. Sontheimer RD (1985). Gamma interferon induces HLA-DR antigen expression by dermal microvascular endothelial cells in vitro [Abstract]. Clin Res, 32, 914A.
    86. Henderson T, Medsger T, Sontheimer RD, Deng J-S (1985). Modification of crithidia immunofluorescence staining and its correlation with Farr assay technique [Abstract]. J Invest Dermatol, 84, 333.
    87. Deng J-S, Sontheimer RD, Lipscomb MF, Gilliam JN (1984). Anti-histone antibodies (AHA) can bind to the Crithidia luciliae (CL) kinetoplast (KIN) [Abstract]. Clin Res, 32, 255A.
    88. Sontheimer RD, Mauney KA (1984). Quantitation of the dermal microvascular response to ultraviolet radiation (UVR) with laser doppler (LD) velocimetry [Abstract]. Clin Res, 32, 259A.
    89. Chang J-Y, Deng J-S, Sontheimer RD, Gilliam JN (1984). Development and characterization of a monoclonal anti-SSA-Ro antibody [Abstract]. Clin Res, 32, 575A.
    90. David KM, Thornton JC, Davis B, Sontheimer RD, Gilliam JN (1984). Morbidity and mortality in patients with subacute cutaneous lupus erythematosus (SCLE) [Abstract]. Clin Res, 32, 578A.
    91. Sontheimer RD and Seeger RC (1984). Distribution of Thy-1 antigen in normal human skin [Abstract]. Clin Res, 32, 616A.
    92. Deng JS, Sontheimer RD, Gilliam JN (1983). Characterization of the relationships between SSA/RO antibodies (Abs), antinuclear anti-bodies (ANA), and subacute cutaneous lupus erythematosus (SLE) [Abstract]. Clin Res, 31, 262A.
    93. Sontheimer RD (1983). Comparison of the mixed lymphocyte reaction (MLR) stimulating capacity of human epidermal Langerhans cells (ELC) and peripheral blood dendritic cells (PBDC) [Abstract]. Clin Res, 31, 601A.
    94. Bangert J, Charley M, Gilliam JN, Sontheimer RD (1983). A comparison of two histologic patterns of murine graft-vs-host skin disease (GVHSD) [Abstract]. Clin Res, 31, 555A.
    95. Charley MR, Gilliam JN, Sontheimer RD (1983). Ultraviolet B exposure converts murine lichenoid graft-vs-host skin disease (GVHSD) into sclerotic GVHSD [Abstract]. Clin Res, 31, 560A.
    96. Dees JH, Charley MR, Sontheimer RD, Gilliam JN (1983). Sequential ultrastructural analysis of murine graft-versus-host skin disease (GVHSD) [Abstract]. Clin Res, 31, 562A.
    97. Chang J-Y, Deng J-S, Sontheimer RD, Gilliam JN (1983). A monoclonal anti-SSA/Ro antibody binds to human but not murine cell nuclei [Abstract]. Clin Res, 920A.
    98. Deng J-S, Nicholes BK, Charley MR, Sontheimer RD, Gilliam JN (1982). Serological studies on mice undergoing chronic graft-versus-host reaction [Abstract]. Clin Res, 30, 914A.
    99. Milewich L, Kaimal V, Sontheimer RD, Gilliam JN (1982). Steroid 5-reductase activity in cultured human epidermal keratinocytes [Abstract]. Clin Res, 30, 492A.
    100. Charley MR, Elmets CA, Hamilton BL, Gilliam JN, Sontheimer RD (1982). Histopathology of graft-versus-host skin disease in mice [Abstract]. Clin Res, 30, 579A.
    101. Sontheimer RD (1982). Comparison of the allogeneic lymphocyte stimulating capacity of human epidermal cells to that of autologous peripheral blood lymphoid cells [Abstract]. J Invest Dermatol, 78, 337.
    102. Sontheimer RD, Reichlin M, Gilliam JN (1982). Inability to identify Ro (SS-A) antigen in normal human skin [Abstract]. Clin Res, 30, 609A.
    103. Charley MR, Mikhael A, Sontheimer RD, Gilliam JN, Bennett M (1982). Mast cell maturation does not depend on an intact bone marrow microenvironment [Abstract]. Clin Res, 30, 913A.
    104. Sontheimer RD, Murphy FK (1981). Cultured human keratinocytes support herpes simplex virus (HSV) replication [Abstract]. Clin Res, 29, 614A.
    105. Sontheimer RD, Bergstresser PR, Gilliam JN (1981). Langerhans cell (LC) involvement in the epidermal (Epid) pathology of cutaneous lupus erythematosus (LE) [Abstract]. Clin Res, 29, 614A.
    106. Bangert J, Freeman RG, Sontheimer RD, Gilliam JN (1981). Comparative analysis of the histopathology of subacute cutaneous lupus erythematosus (SCLE) and discoid lupus erythematosus (DLE) [Abstract]. Clin Res, 29, 587A.
    107. Sontheimer RD, Gilliam JN (1981). Human epidermal Langerhans cells (ELC) are more efficient than autologous peripheral blood mononuclear cells (Auto-PBMC) in stimulating allogeneic peripheral blood lymphocytes (Allo-PBL) [Abstract]. Fed Proceed, 40, 1165.
    108. Sontheimer RD, Bergstresser PR, Gailiunas P, Helderman H, Gilliam JN (1981). Epidermal (Epid) Langerhans cells (ELC) in chronically immunosuppressed (CI) human renal allograft recipients (HRAR) [Abstract]. Clin Res, 29, 502A.
    109. Sontheimer RD, Stastny P, Maddison P, Reichlin M, Gilliam JN (1980). Anti-Ro and La antibodies and further HLA associations in subacute cutaneous lupus erythematosus (SCLE) [Abstract]. Arthritis Rheum, 23, 750.
    110. Sontheimer RD, Stastny P, Maddison P, Reichlin M, Gilliam JN (1980). Immunological and HLA associations in subacute cutaneous lupus erythematosus (SCLE) [Abstract]. J Invest Dermatol, 74, 260.
    111. Sontheimer RD, Gilliam JN (1979). The clinical and laboratory features of patients with subacute cutaneous lupus erythematosus (SCLE) — A distinct lupus erythematosus (LE) subset [Abstract]. Arthritis Rheum, 22, 660.
    112. Sontheimer RD, Thomas JR, Gilliam JN (1978). The clinical and immunological features of patients with subacute cutaneous lupus erythematosus — a distinct lupus erythematosus subset [Abstract]. J Invest Dermatol, 71, 278.
    113. Sontheimer RD, Gilliam JN (1977). Detection of complement-fixing DNA antibodies in SLE by immunofluorescence [Abstract]. Clin Res, 25, 368A.
    114. Gilliam JN, Sontheimer RD (1977). Comparison of subepidermal immunoglobulin and DNA antibody in male and female NZB/W mice [Abstract]. Clin Res, 25, 282A.
    115. Sontheimer RD, Krueger GG, Chapman HA, et al (1977). Adrenal androgen over-responsiveness to ACTH in females with severe acne without evidence of 11 or 21 hydroxylase deficiency [Abstract]. Clin Res, 25, 287A.
    116. Sontheimer RD, Gilliam JN (1977). Comparison of uninvolved skin subepidermal Ig and circulating native DNA antibodies in patients with lupus erythematosus [Abstract]. J Invest Dermatol, 69, 423.

    Newspaper

    1. Sontheimer RD (2012). Clinical Focus. Six things these erythematous lower leg skin changes could be caused by, other than cellulitis. Practicial Dermatology for Primary Care Course Newsletter, Vol 1, No. 1, 2012.
    2. Sontheimer RD (2012). Online management resources for dermatologic diseases. Practical Dermatology for Primary Care Course Newsletter, Vol 1, No. 1, 2012.

    Other

    1. Sontheimer RD (2018). Introduction for a New Column Manuscript Category for Annals of Translational Medicine - "Changemakers in Patient-Oriented Translational Clinical Investigation" http://atm.amegroups.com/post/view/introduction-for-a-new-column-manuscript-category-for-annals-of translational-medicine-ndash-1dquo-changemakers-in-patient-oriented-translational-clinical-investigation-rdquo. Ann Transl Med.
    2. Schultz HY, Dutz JP, Furukawa F, Goodfield MJ, Kuhn A, Lee LA, Nyberg F, Szepietowski JC, Sontheimer RD, Werth VP (2015). From pathogenesis, epidemiology, and genetics to definitions, diagnosis, and treatments of cutaneous lupus erythematosus and dermatomyositis: a report from the 3rd International Conference on Cutaneous Lupus Erythematosus (ICCLE) 2013. J Invest Dermatol (135(1), pp. 7-12). United States. (Read full article)
    3. Cooper KD, Sontheimer RD, Dutz J, Hwang ST, Nickoloff BJ, Shimada S, Kulesz-Martin M, Bickenbach JR (2008). 56th annual Montagna Symposium on the Biology of Skin: Epidermal T-cell interactions--clinicopathological and basic mechanisms. J Invest Dermatol (128(6), pp. 1351-3). United States. (Read full article)
    4. Sontheimer RD (2002). Why do fingers and toes wrinkle after a long bath? Letter to the Editor. Discover Magazine.
    5. Sontheimer RD (2001). Radio interview with Roy Justis, KXIC, on "Melanoma".
    6. Sontheimer RD (2000). Radio interview with Roy Justis, KXIC, on "Scleroderma and Lupus".
    7. Sontheimer RD (2000). Interview with Dean Borg, Health Beat, on "Lupus" during Lupus Awareness Month. Health Beat is a weekly radio broadcast sponsored by UI Health Care. Health Beat can be heard on radio stations in Iowa, Illinois, and Oklahoma.
    8. Sontheimer RD (2000). Radio interview with Roy Justis, KXIC, on "Lupus" during Lupus Awareness Month in association with the University of Iowa Hospitals and Clinics Joint Office of Planning, Marketing and Communication.
    9. Sontheimer RD (2000). Radio interview with Ryan Schlader, WMT, on "Lupus" during Lupus Awareness Month in association with the University of Iowa Hospitals and Clinics Joint Office of Planning, Marketing and Communication.
    10. Sontheimer RD (1999). Who will find the next dermatological breakthrough? Managed Care Magazine.
    11. Sontheimer RD (1999). A glossary of modern health care economics: platitudes and principles gleaned from the first year's education of a new academic health care delivery center department head. Arch Dermatol (135(10), pp. 1248-54). United States. (Read full article)
    12. Sontheimer RD (1999). Thalidomide makes a come back as a treatment for skin conditions. University of Iowa Hospitals and Clinics Pacemaker.
    13. Sontheimer RD (1999). TV interview on the use of Thalidomide for difficult skin diseases.
    14. Sontheimer RD (1999). Interview on the use of Thalidomide for difficult skin diseases. National Public Radio.
    15. Sontheimer RD (1994). Roundtable discussion of the prospects for developing a new classification of cutaneous LE. Fitzpatrick's J Clin Dermatol.
    16. Pandya A, Cruz P, Wiley EL, Sontheimer RD (1990). Disseminated histoplasmosis presenting as ecthyma gangrenosum. Case Report. Clinical Cases in Dermatology (2, pp. 6-12).
    17. Sontheimer RD (1984). Clinical significance of double stranded DNA antibodies. Schoch Letter (34, p. 40).

    Video/Film/CD/Web/Podcast

    1. Sontheimer RD (2015). When it comes to end-of-life care, perhaps we do need a bigger hammer [Web]. Kevin MD.com.
    2. Sontheimer RD (2014). "Dermatomyositis" Is No Longer Enough (a commentary on Valenzuela A et al: Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis) [Web]. JAMA Dermatology. Available: http://archderm.jamanetwork.com/article.aspx?articleid=1876054&resultClick=3.
    3. Sontheimer RD (2014). What are the Basics of Connective Tissue Disease in the Skin? Society of Dermatology Physicians Assistants Conference, Indianapolis, IN [Podcast].
    4. Sontheimer RD (2000). AmericasDoctor.Com: Online question-and-answer discussion on skin problems in patients with arthritis-related diseases, 1 hour [Web].

    Patent

    1. Sontheimer RD (2001). DNA segments in coding autoimmune polypeptides epitopes of Ro/SS-a antigens Date filed -- May 24, 1991; Patent owned by Board of Regents, University of Texas. U.S. Patent No. 6303339. Washington, D.C.:U.S. Patent and Trademark Office.